{
  "meta": {
    "title": "00247_Late_Night_Pyqs_Neetpg-1",
    "url": "https://brainandscalpel.vercel.app/00247-late-night-pyqs-neetpg-1-bf947b72.html",
    "scrapedAt": "2025-11-29T17:27:59.349Z"
  },
  "questions": [
    {
      "id": 80089,
      "choices": [
        {
          "id": 319072,
          "text": "<p><span style=\"font-size:12.0pt;\">50 breaths per minute or more</span></p>"
        },
        {
          "id": 319073,
          "text": "<p><span style=\"font-size:12.0pt;\">10 or more skin pustules</span></p>"
        },
        {
          "id": 319074,
          "text": "<p><span style=\"font-size:12.0pt;\">Axillary temperature of 37.5°C or above</span></p>"
        },
        {
          "id": 319075,
          "text": "<p><span style=\"font-size:12.0pt;\">Temperature less than 35.5°C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following does NOT suggest a possible severe bacterial infection in a young infant according to the IMNCI criteria? (NEET PG 2015)</span></p>",
      "unique_key": "Q6852301",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947323,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: C. Axillary temperature of 37.5°C or above&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The IMNCI (Integrated Management of Neonatal and Childhood Illness) protocol uses specific clinical criteria to identify young infants with potential severe bacterial infections requiring urgent treatment. An axillary temperature of 37.5°C represents a normal body temperature and falls below the fever threshold of ≥38.0°C, which would indicate infection. A temperature between 36.5°C and 37.5°C is considered normal and would not trigger the \"fever\" classification in the IMNCI assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The WHO IMNCI classification system specifically designates fever as temperature ≥38°C when assessing for possible severe bacterial infection. Without other clinical signs, a temperature of 37.5°C alone would be classified as \"no fever\" and would not meet criteria for antibiotic therapy or referral.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 50 breaths per minute or more</strong> - This is a danger sign in IMNCI assessment. The age-specific respiratory rate cutoffs (≥60/min for &lt;2 months; ≥50/min for 2-12 months) define fast breathing, which is classified as pneumonia requiring antibiotic therapy or severe pneumonia if accompanied by chest indrawing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 10 or more skin pustules</strong> - This IS considered a sign of possible severe bacterial infection. The IMNCI guidelines classify multiple skin pustules or a large skin infection as requiring systemic antibiotics due to risk of invasive bacterial disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Temperature less than 35.5°C</strong> - This IS a critical danger sign. Hypothermia in young infants strongly suggests sepsis and represents impaired thermoregulation. IMNCI classifies temperature &lt;35.5°C as a danger sign requiring immediate referral after pre-referral antibiotics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In IMNCI assessment, normal temperature (36.5-37.5°C) does not trigger concern for severe bacterial infection, while fast breathing (age-specific rates), multiple skin infections, and hypothermia (&lt;35.5°C) all represent important clinical signs requiring prompt antibiotic therapy and possible referral.</span></p>",
      "correct_choice_id": 319074,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76168,
      "choices": [
        {
          "id": 303545,
          "text": "<p><span style=\"font-size:16px;\">10%</span></p>"
        },
        {
          "id": 303546,
          "text": "<p><span style=\"font-size:16px;\">20%</span></p>"
        },
        {
          "id": 303547,
          "text": "<p><span style=\"font-size:16px;\">50%</span></p>"
        },
        {
          "id": 303548,
          "text": "<p><span style=\"font-size:16px;\">60%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">In a community, a new disease led to 60 cases occurring in a year. There were 12 deaths in the given year due to the same disease. Calculate the case fatality rate for this new disease. (FMGE JAN 2025)</span></p>",
      "unique_key": "Q8870471",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947172,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans. B) 20%</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Case Fatality Rate (CFR) is calculated using the formula:</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul><li><span style=\"font-size:16px;\">CFR&nbsp;</span></li><li><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KbCzmU0.png\" width=\"912\" height=\"94\"></span></li><li><span style=\"font-size:16px;\">In this case: CFR = (12/60) × 100 = 20%</span></li><li><span style=\"font-size:16px;\">CFR is a proportion (not a rate) where numerator is part of denominator</span></li><li><span style=\"font-size:16px;\">It indicates that out of 100 cases of this disease, 20 are likely to die</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_kvKRlno.png\" width=\"919\" height=\"127\"></span><br>&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">It is a proportion (not a rate) that indicates the percentage of cases of a disease that result in death.</span></p>",
      "correct_choice_id": 303546,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44550,
      "choices": [
        {
          "id": 177847,
          "text": "<p><span style=\"font-size:12.0pt;\">Scrofuloderma</span></p>"
        },
        {
          "id": 177848,
          "text": "<p><span style=\"font-size:12.0pt;\">Lupus Vulgaris</span></p>"
        },
        {
          "id": 177849,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis Verrucosa Cutis</span></p>"
        },
        {
          "id": 177850,
          "text": "<p><span style=\"font-size:12.0pt;\">Any of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which form of cutaneous tuberculosis is typically contracted from direct skin inoculation in individuals with good immunity? (NEET PG 2017)</span></p>",
      "unique_key": "Q6521747",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947315,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Tuberculosis Verrucosa Cutis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Tuberculosis verrusosa cutis (TBVC)</strong> is the form of cutaneous tuberculosis that results from direct <strong>inoculation</strong> of Mycobacterium tuberculosis into the skin of individuals with <strong>good immunity</strong>.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">It is also called <strong>\"Anatomist's wart\" or \"Pathologist's wart\"</strong> because of its occupational association.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">TVC presents as an indurated <strong>verrucous plaque</strong> that develops at the site of inoculation, typically on <strong>trauma-prone</strong> sites like the <strong>extremities.&nbsp;</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img class=\"image_resized\" style=\"aspect-ratio:318/228;width:58.3%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture40.png\" width=\"318\" height=\"228\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Due to the patient's good immunity, this is a<strong> paucibacillary form</strong> of cutaneous TB where the infection remains localized.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Scrofuloderma:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Scrofuloderma is an <strong>endogenous form</strong> of cutaneous tuberculosis that occurs through contiguous spread from an underlying tuberculous focus (<strong>lymph node, bone, joint)</strong> to the overlying skin.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture41.png\" width=\"2597\" height=\"866\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">It is not acquired through direct skin inoculation.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Scrofuloderma is characterized by <strong>painless subcutaneous swellings</strong> that break down to form discharging <strong>sinuses</strong> with <strong>undermined edges.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lupus Vulgaris:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Lupus Vulgaris can occur through <strong>both endogenous (hematogenous spread)</strong> and, less commonly, <strong>exogenous</strong> routes, but it typically affects individuals with moderate immunity rather than good immunity.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">It presents as a <strong>plaque</strong> with an active, <strong>advancing margin and central scarring.&nbsp;</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img class=\"image_resized\" style=\"aspect-ratio:369/314;width:61.15%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture42.png\" width=\"369\" height=\"314\"></strong></span></p><p>&nbsp;</p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">While it can occasionally be acquired through direct inoculation, it's not the typical presentation in individuals with good immunity, so <strong>TBVC</strong> is the better option to choose.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Any of the above:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Only Tuberculosis Verrucosa Cutis is specifically associated with direct skin inoculation in individuals with good immunity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Tuberculosis Verrucosa Cutis</strong> is distinguished as the form of <strong>cutaneous TB</strong> acquired through <strong>exogenous inoculation</strong> in individuals with <strong>good immunity</strong>, presenting as a<strong> localized verrucous plaque at trauma-prone</strong> sites, particularly on the extremities.</span></li></ul>",
      "correct_choice_id": 177849,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57287,
      "choices": [
        {
          "id": 228529,
          "text": "<p><span style=\"font-size:12.0pt;\">Extrapulmonary TB like Tubercular meningitis</span></p>"
        },
        {
          "id": 228530,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin resistance with both KatG and inhA mutation</span></p>"
        },
        {
          "id": 228531,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin-sensitive TB</span></p>"
        },
        {
          "id": 228532,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin-resistant but fluoroquinolone-sensitive TB</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is an inclusion criterion for the shorter bedaquiline regimen in the treatment of tuberculosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q9248071",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947170,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Rifampicin-resistant but fluoroquinolone-sensitive TB</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The shorter bedaquiline regimen is specifically designed for treating certain cases of drug-resistant tuberculosis. It is typically indicated in cases of <strong>Rifampicin-resistant (RR) tuberculosis</strong> or <strong>multidrug-resistant (MDR) tuberculosis</strong> under certain conditions. This regimen is used when the tuberculosis strain is resistant to Rifampicin, but it remains sensitive to fluoroquinolones.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Additionally, in cases where there is resistance to Isoniazid (INH), the shorter regimen can be used if the resistance is due to a mutation in either the KatG or inhA gene, but not both.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">If both mutations are present, or if the TB is severe or extrapulmonary, the shorter regimen is not recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Extrapulmonary TB like Tubercular meningitis:&nbsp;</strong>The shorter bedaquiline regimen is not indicated for extrapulmonary TB, as it is intended for pulmonary TB only. Extrapulmonary TB often requires a longer and more complex treatment regimen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Rifampicin resistance with both KatG and inhA mutation:&nbsp;</strong>This scenario represents a more complex form of MDR-TB where resistance occurs due to mutations in both the KatG and inhA genes. The presence of both mutations generally excludes the use of the shorter regimen, as a longer and more intensive treatment is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Rifampicin-sensitive TB:&nbsp;</strong>The shorter bedaquiline regimen is not indicated for Rifampicin-sensitive TB. This regimen is specifically designed for drug-resistant cases, particularly those resistant to Rifampicin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Bedaquiline shorter regimen is indicated for the treatment of -</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Rifampicin-resistant TB (FQ sensitive) or MDR TB</span></li><li><span style=\"font-size:12pt;\">INH Resistant TB – due to mutation in either inhA or Kat G gene (NOT BOTH)</span></li><li><span style=\"font-size:12pt;\">Pulmonary TB</span></li></ul>",
      "correct_choice_id": 228532,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6526,
      "choices": [
        {
          "id": 26073,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin Immune Fab</span></p>"
        },
        {
          "id": 26074,
          "text": "<p><span style=\"font-size:12.0pt;\">Lidocaine</span></p>"
        },
        {
          "id": 26075,
          "text": "<p><span style=\"font-size:12.0pt;\">DC cardioversion</span></p>"
        },
        {
          "id": 26076,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenytoin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was brought to the emergency room after consuming 8 digoxin tablets. On examination, he was found to be unstable, with a heart rate of 56 beats per minute. An ECG revealed a third-degree heart block. What is the next step in this patient's care? (NEET PG 2022)</span></p>",
      "unique_key": "Q3783201",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947318,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Digoxin Immune Fab</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For the management of Digoxin toxicity having the features of Bradycardia and a 3<sup>rd</sup> degree heart block, we need to administer Digibind, which is an antibody against Digoxin. It is also known as Digoxin immune Fab.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lidocaine:&nbsp;</strong>Lidocaine<strong> </strong>is used to treat Ventricular Tachycardia or Ventricular Fibrillation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. DC cardioversion:&nbsp;</strong>DC cardioversion is used for tachyarrhythmias when pharmacologic treatment fails. It is not used in bradyarrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phenytoin:&nbsp;</strong>Phenytoin is an antiepileptic used for the treatment of GTCS. It can also be used as a class Ib antiarrhythmic drug for the treatment of Digoxin induced Ventricular Tachycardia, or any polymorphic ventricular tachycardia due to QT prolongation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The administration of Digoxin Immune Fab is the next step in the management of life-threatening digoxin toxicity, particularly in the presence of bradycardia and third-degree heart block.</span></p>",
      "correct_choice_id": 26073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6507,
      "choices": [
        {
          "id": 25997,
          "text": "<p><span style=\"font-size:12.0pt;\">Timolol</span></p>"
        },
        {
          "id": 25998,
          "text": "<p><span style=\"font-size:12.0pt;\">Gemeprost</span></p>"
        },
        {
          "id": 25999,
          "text": "<p><span style=\"font-size:12.0pt;\">Latanoprost</span></p>"
        },
        {
          "id": 26000,
          "text": "<p><span style=\"font-size:12.0pt;\">Mannitol infusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following can be prescribed in case of an open angle glaucoma with bronchial asthma? (NEET PG 2021)</span></p>",
      "unique_key": "Q4775624",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947167,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Latanoprost</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Latanoprost is a Prostaglandin, PGF2α analog, that acts in glaucoma by increasing the uveoscleral outflow of aqueous humor and is used as a first line drug in patients with open angle glaucoma. It can be safely used in bronchial asthma, as it does not cause bronchospasm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Timolol</strong>: Timolol is a beta-blocker that can cause bronchospasm as a systemic side effect. Therefore, it is not recommended for patients with bronchial asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Gemeprost</strong>: Gemeprost is a prostaglandin E1 (PGE1) analog used for the termination of pregnancy. It is not relevant for the treatment of glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mannitol infusion</strong>: Mannitol is an osmotic diuretic used in the treatment of acute angle-closure glaucoma, not open-angle glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Latanoprost, a prostaglandin F2α analog, is safe and effective for the treatment of open-angle glaucoma in patients with bronchial asthma, as it does not cause bronchospasm.</span></p>",
      "correct_choice_id": 25999,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44899,
      "choices": [
        {
          "id": 179243,
          "text": "<p><span style=\"font-size:12.0pt;\">Psoriasis</span></p>"
        },
        {
          "id": 179244,
          "text": "<p><span style=\"font-size:12.0pt;\">Pityriasis rosea</span></p>"
        },
        {
          "id": 179245,
          "text": "<p><span style=\"font-size:12.0pt;\">Seborrheic dermatitis</span></p>"
        },
        {
          "id": 179246,
          "text": "<p><span style=\"font-size:12.0pt;\">Pityriasis lichenoides chronica</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which condition is characterized by the presence of mica-like adherent scales? (NEET PG 2017)</span></p>",
      "unique_key": "Q7438265",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947165,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Pityriasis lichenoides chronica</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Pityriasis lichenoides chronica (PLC)</strong> is specifically characterized by <strong>mica-like adherent scales.&nbsp;</strong></span></li><li><span style=\"font-size:12.0pt;\">This chronic papulosquamous condition presents with <strong>polymorphic eruptions</strong> of successive crops of asymptomatic <strong>red-brown papules</strong>, which are surmounted by a central, adherent <strong>mica-like scale.&nbsp;</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/24.jpg\" width=\"900\" height=\"412\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">These scales have a distinctive shiny, flaky appearance resembling <strong>mica minera</strong>l.&nbsp;</span></li></ul><p>&nbsp;</p><p><img class=\"image_resized\" style=\"aspect-ratio:502/579;width:77.96%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/104_XdK8EtL.png\" width=\"502\" height=\"579\"></p><p>&nbsp;</p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The lesions of PLC heal with <strong>hypopigmentation</strong> and commonly affect the <strong>trunk and proximal&nbsp;</strong>parts of the<strong> extremities.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Psoriasis:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><ul><li><span style=\"font-size:12.0pt;\">Psoriasis features <strong>silvery white, loose, lamellar scales</strong> rather than mica-like adherent scales.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/25.jpg\" width=\"1143\" height=\"394\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">These scales are easily removable and when scraped, demonstrate the <strong>Auspitz sign</strong> (pinpoint bleeding spots).&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Psoriatic scales are described as<strong> micaceous, silvery white</strong>, but they are <strong>not adherent</strong> like those in PLC.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pityriasis rosea:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pityriasis rosea is characterized by a <strong>collarette of scales</strong> on the leading edge of lesions, not mica-like adherent scales.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">The scales in pityriasis rosea have their outer edge attached within the active margin of the lesion, while the inner edge remains free (which produces the <strong>\"hanging curtain sign\"</strong> when stretched).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Seborrheic dermatitis:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Seborrheic dermatitis features <strong>greasy or yellowish scales</strong> rather than mica-like adherent scales.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/26.jpg\" width=\"900\" height=\"445\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">These scales are typically found in <strong>sebum-rich areas</strong> of the body, such as the scalp, face, and flexures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-03%20175019.png\" width=\"975\" height=\"535\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Pityriasis lichenoides chronica</strong> is distinguished by its <strong>mica-like adherent scales</strong> surmounting red-brown papules, which heal with characteristic <strong>hypopigmentation&nbsp;</strong>— a key diagnostic feature that differentiates it from other papulosquamous disorders.</span></li></ul>",
      "correct_choice_id": 179246,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80904,
      "choices": [
        {
          "id": 322300,
          "text": "<p><span style=\"font-size:12.0pt;\">Panic Attacks</span></p>"
        },
        {
          "id": 322301,
          "text": "<p><span style=\"font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 322302,
          "text": "<p><span style=\"font-size:12.0pt;\">Anxiety Disorders</span></p>"
        },
        {
          "id": 322303,
          "text": "<p><span style=\"font-size:12.0pt;\">Stressful situations</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The General Adaptation Syndrome (GAS) primarily describes the body's response to which of the following?</span><span style=\"font-size:16px;\"> (NEET PG 2016)</span></p>",
      "unique_key": "Q2842228",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947164,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. Stressful situations</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The General Adaptation Syndrome (GAS) is a model developed by Hans Selye that describes the body's physiological response to stress. It outlines how the body responds to any demand (stressor) placed upon it, regardless of whether the stressor is physical, psychological, or environmental. The GAS consists of three stages: alarm reaction (fight-or-flight response), resistance (adaptation), and exhaustion. It represents a general biological response to stress rather than being specific to any particular psychiatric condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Panic Attacks (Incorrect)</strong>: While panic attacks involve physiological stress responses, they represent a specific type of anxiety response rather than the general stress response described by GAS. Panic attacks are acute episodes characterized by intense fear and specific physical symptoms like palpitations, sweating, and shortness of breath.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Depression (Incorrect)</strong>: Depression represents a mood disorder with persistent low mood, anhedonia, and other emotional and physical symptoms. While chronic stress can contribute to depression, and there may be HPA axis dysregulation in depression, GAS describes the general stress response rather than the specific pathophysiology of depression.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Anxiety Disorders (Incorrect)</strong>: Anxiety disorders involve excessive worry, fear, and physiological arousal. While anxiety certainly involves stress response systems, GAS describes the broader physiological response to any stressor, not just anxiety disorders.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The General Adaptation Syndrome (GAS) is a fundamental model describing how the body responds physiologically to any type of stressor through three stages: alarm reaction, resistance, and exhaustion. It involves the hypothalamic-pituitary-adrenal (HPA) axis and represents a non-specific response to stress rather than being particular to any specific psychiatric condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-15%20161417.png\" width=\"1022\" height=\"360\"></span></p>",
      "correct_choice_id": 322303,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80906,
      "choices": [
        {
          "id": 322308,
          "text": "<p><span style=\"font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 322309,
          "text": "<p><span style=\"font-size:12.0pt;\">Resistant Schizophrenia</span></p>"
        },
        {
          "id": 322310,
          "text": "<p><span style=\"font-size:12.0pt;\">Obsessive-Compulsive Disorder</span></p>"
        },
        {
          "id": 322311,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Psychosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Repeated Transcranial Magnetic Stimulation (rTMS) of the brain has been FDA-approved for the treatment of which of the following conditions?</span><span style=\"font-size:16px;\"> (NEET PG 2016)</span></p>",
      "unique_key": "Q5902082",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947174,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: A. Depression</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Repetitive Transcranial Magnetic Stimulation (rTMS) has been approved by the FDA for the treatment of major depressive disorder. rTMS uses rapidly changing magnetic fields to produce small electric currents (known as eddy currents) in superficial cortical neurons\" and is \"approved as a treatment modality in major depressive disorder.\" It is typically used for patients with depression who have not responded adequately to antidepressant medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option B. Resistant Schizophrenia (Incorrect)</strong>: While there is ongoing research into the potential benefits of rTMS for various symptoms of schizophrenia, it is not FDA-approved for the treatment of resistant schizophrenia. Clozapine remains the standard treatment for treatment-resistant schizophrenia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Obsessive-Compulsive Disorder (Incorrect)</strong>: Deep TMS was approved by the FDA for the treatment of OCD in 2018. At the time this question was written, option C was incorrect; however, as of today, it would also be considered a correct option.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Acute Psychosis (Incorrect)</strong>: rTMS is not FDA-approved for the treatment of acute psychosis. Antipsychotic medications are the primary treatment for acute psychotic episodes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive brain stimulation technique that has the FDA approval for the following psychiatric disorders:</span></p><ol><li><span style=\"font-size:12.0pt;\">Major Depressive Disorder (MDD)&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Obsessive-Compulsive Disorder (OCD)&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Anxious Depression&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Smoking Cessation&nbsp;</span></li></ol>",
      "correct_choice_id": 322308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55643,
      "choices": [
        {
          "id": 222017,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage I</span></p>"
        },
        {
          "id": 222018,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage II</span></p>"
        },
        {
          "id": 222019,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage III</span></p>"
        },
        {
          "id": 222020,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old female has appreciable shortening in her right leg. She is diagnosed with TB Hip. Her presentation will come under which stage? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q8648039",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947321,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Stage III</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>STAGES OF TUBERCULOSIS OF HIP</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Stage 1:&nbsp;</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Stage of synovitis</span></li><li><span style=\"font-size:16px;\">FABER<strong>&nbsp;</strong>(Flexion, Abduction and External rotation)</span></li><li><span style=\"font-size:16px;\">Lengthening</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Stage 2:&nbsp;</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Stage of early arthritis</span></li><li><span style=\"font-size:16px;\">FADIR (Flexion, Adduction and Internal rotation)&nbsp;</span></li><li><span style=\"font-size:16px;\">&lt;1 cm shortening</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Stage 3:&nbsp;</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Stage of advanced arthritis</span></li><li><span style=\"font-size:16px;\">FADIR (Flexion, Adduction and Internal rotation)&nbsp;</span></li><li><span style=\"font-size:16px;\">&gt;1 cm shortening</span></li><li><span style=\"font-size:16px;\">Appreciable shortening is a key characteristic.</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Stage 4:&nbsp;</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Stage of subluxation/dislocation</span></li><li><span style=\"font-size:16px;\">Wandering acetabulum or pestle and mortar appearance</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Stage 5:&nbsp;</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Stage of sequelae, ankylosis or severe arthritis</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20110113.jpg\" width=\"568\" height=\"307\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Wandering acetabulum (actually wandering femur head)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20110126.jpg\" width=\"471\" height=\"365\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Additionally,</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Stage V:&nbsp;</strong>Described as a \"<strong>fused, finished off joint</strong>\" known as <strong>fibrous ankylosis</strong>. This stage represents the end progression of certain joint diseases where there is complete fusion of the joint surfaces.</span></li><li><span style=\"font-size:16px;\">In TB affecting peripheral joints, such as the hip and knee, the fusion is more commonly <strong>fibrous ankylosis</strong>, where the fusion involves more fibrous tissue rather than direct bone fusion. This is painful condition.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Stage I:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Known as the stage of synovitis.</span></li><li><span style=\"font-size:16px;\">Characterized by increased capacity of the hip.</span></li><li><span style=\"font-size:16px;\">The position of comfort is FABER (flexion, abduction, external rotation).</span></li><li><span style=\"font-size:16px;\">FABER leads to lengthening of the leg, not shortening.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Stage II:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Early arthritis stage with joint damage.</span></li><li><span style=\"font-size:16px;\">The lower limb adopts a position of flexion, adduction, and internal rotation.</span></li><li><span style=\"font-size:16px;\">Shortening is present but is &gt; 1 cm and not appreciable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Stage IV:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Involves destruction of the bone and changes in the shape of the joint.</span></li><li><span style=\"font-size:16px;\">The femoral head migrates, causing subluxation or dislocation.</span></li><li><span style=\"font-size:16px;\">Known as the stage of the wandering acetabulum, a misnomer for the wandering femoral head.</span></li><li><span style=\"font-size:16px;\">Not specifically associated with the appreciable shortening described in the question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Stage III of TB hip is characterized by late or advanced arthritis with appreciable shortening of the leg (&gt; 1 cm).</span></li></ul>",
      "correct_choice_id": 222019,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55642,
      "choices": [
        {
          "id": 222013,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
        },
        {
          "id": 222014,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B</span></p>"
        },
        {
          "id": 222015,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin C</span></p>"
        },
        {
          "id": 222016,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Rickets occurs due to deficiency of: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q9427839",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947311,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D)&nbsp;Vitamin</strong> <strong>D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Rickets is a <strong>skeletal disorder</strong> that results from a <strong>deficiency of Vitamin D, calcium, or phosphate</strong>.&nbsp;</span></li><li><span style=\"font-size:16px;\">The <strong>primary cause</strong> of rickets is a <strong>lack of Vitamin D</strong>, which is <strong>essential for the absorption of calcium and phosphate</strong> in the body.&nbsp;</span></li><li><span style=\"font-size:16px;\">Without adequate Vitamin D, <strong>bones can become soft and weak</strong>.</span></li><li><span style=\"font-size:16px;\"><strong>Key features of rickets include:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>Cupping:</strong> The <strong>metaphyseal ends</strong> of bones become <strong>cup-shaped</strong>.</span></li><li><span style=\"font-size:16px;\"><strong>Splaying:</strong> An <strong>increase in the width of the metaphyseal ends</strong>.</span></li><li><span style=\"font-size:16px;\"><strong>Flaring:</strong> The <strong>ends</strong> of the bones <strong>point outward</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20110046.jpg\" width=\"779\" height=\"377\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">These characteristics are <strong>critical diagnostic features</strong> of rickets and help differentiate it from other bone disorders.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A.&nbsp;Vitamin</strong> <strong>A:</strong> Vitamin A deficiency can lead to issues like night blindness and impaired immunity.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B.&nbsp;Vitamin</strong> <strong>B:</strong> B vitamins are crucial for energy production and neurological function.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C.&nbsp;Vitamin</strong> <strong>C:</strong> Vitamin C deficiency causes scurvy, which presents with symptoms like bleeding gums and joint pain. In vitamin C deficiency, the bony ends appear more white on radiographs (Whitening).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20110058.jpg\" width=\"403\" height=\"364\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Rickets is primarily caused by a deficiency of Vitamin D, which leads to characteristic bone deformities such as cupping, splaying, and flaring of the metaphyseal ends.</span></li></ul>",
      "correct_choice_id": 222016,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76172,
      "choices": [
        {
          "id": 303561,
          "text": "<p><span style=\"font-size:16px;\">80.5 - 83.5 kg</span></p>"
        },
        {
          "id": 303562,
          "text": "<p><span style=\"font-size:16px;\">79 - 85 kg</span></p>"
        },
        {
          "id": 303563,
          "text": "<p><span style=\"font-size:16px;\">80.5 - 86.5 kg</span></p>"
        },
        {
          "id": 303564,
          "text": "<p><span style=\"font-size:16px;\">82 - 88 kg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">In a normal distribution for weights of a class of college students, Mean value is 82 kg. The calculated SD is 1.5 kg. Calculate the range of weight for 95% students covering 2 SD. (FMGE JAN 2025)</span></p>",
      "unique_key": "Q6942919",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947312,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) 79 – 85 kg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In a normal distribution:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Mean ± 2SD covers 95% of all values</span></li><li><span style=\"font-size:16px;\">Formula: Range = Mean ± (2 × SD)</span></li><li><span style=\"font-size:16px;\">Given: Mean = 82 kg, SD = 1.5 kg</span></li><li><span style=\"font-size:16px;\">Therefore: Range = 82 ± (2 × 1.5) = 82 ± 3 = 79 to 85 kg This means 95% of students will have weights between 79 and 85 kg.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In a normal distribution:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Mean ± 1SD includes 68% of values</span></li><li><span style=\"font-size:16px;\">Mean ± 2SD includes 95% of values</span></li><li><span style=\"font-size:16px;\">Mean ± 3SD includes 99.7% of values</span></li></ul>",
      "correct_choice_id": 303562,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6525,
      "choices": [
        {
          "id": 26069,
          "text": "<p><span style=\"font-size:12.0pt;\">DNA gyrase inhibition</span></p>"
        },
        {
          "id": 26070,
          "text": "<p><span style=\"font-size:12.0pt;\">Ribosomal inhibition</span></p>"
        },
        {
          "id": 26071,
          "text": "<p><span style=\"font-size:12.0pt;\">Cell wall synthesis inhibition</span></p>"
        },
        {
          "id": 26072,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of folic acid synthesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman presenting with symptoms of urinary tract infection was prescribed a drug that causes tendon rupture and arthropathy. What is the mechanism of action of the drug? (NEET PG 2022)</span></p>",
      "unique_key": "Q4043804",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947188,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) DNA gyrase inhibition</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The description of a drug causing tendon rupture and arthropathy, especially in the context of treating a urinary tract infection, points towards a fluoroquinolone antibiotic. Fluoroquinolones, such as ciprofloxacin, work by inhibiting bacterial DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication and transcription.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ribosomal Inhibition:</strong> Antibiotics that inhibit ribosomes, such as macrolides, tetracyclines, and aminoglycosides, affect protein synthesis. These drugs are not typically associated with tendon rupture or arthropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cell Wall Synthesis Inhibition</strong>: Drugs that inhibit cell wall synthesis, like beta-lactams (penicillins, cephalosporins) and vancomycin, are not known to cause tendon rupture or arthropathy as a common side effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Inhibition of Folic Acid Synthesis</strong>: Antibiotics that inhibit folic acid synthesis, such as sulfonamides and trimethoprim, do not typically cause tendon rupture or arthropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fluoroquinolones, which inhibit DNA gyrase and topoisomerase IV, are associated with serious side effects such as tendon rupture and arthropathy.</span></p>",
      "correct_choice_id": 26069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44868,
      "choices": [
        {
          "id": 179119,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3 and 4</span></p>"
        },
        {
          "id": 179120,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, 2 and 4</span></p>"
        },
        {
          "id": 179121,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, 4 and 2</span></p>"
        },
        {
          "id": 179122,
          "text": "<p><span style=\"font-size:12pt;\">4, 2, 1 and 3</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Many GPCR receptors act via increase in cAMP. There are several steps involved in this mechanism as given below. Which of the following is correct sequence of events in cAMP signal transduction pathway? (</span>INICET May 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Steps involved</span></p><p><br><span style=\"font-size:12.0pt;\">1. Activation of adenylate cyclase</span><br><span style=\"font-size:12.0pt;\">2. Activation of PKA</span><br><span style=\"font-size:12.0pt;\">3. Conversion of ATP to cAMP</span><br><span style=\"font-size:12.0pt;\">4. Phosphorylation of target proteins</span></p>",
      "unique_key": "Q2011234",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947186,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 1, 3, 2 and 4</strong></span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\">The correct sequence of events in the cAMP signal transduction pathway is:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Activation of adenylate cyclase</span></li><li><span style=\"font-size:12pt;\">Conversion of ATP to cAMP</span></li><li><span style=\"font-size:12pt;\">Activation of PKA</span></li><li><span style=\"font-size:12pt;\">Phosphorylation of target proteins</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. 1, 3, 2 and 4</strong></span></p>",
      "correct_choice_id": 179120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57288,
      "choices": [
        {
          "id": 228533,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dhatura poisoning</span></span></p>"
        },
        {
          "id": 228534,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcohol intoxication</span></span></p>"
        },
        {
          "id": 228535,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioid overdose</span></span></p>"
        },
        {
          "id": 228536,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cocaine poisoning</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient is found on a railway track with hot dry skin, raised temperature, dilated pupils, slurred speech, and a staggering gait. Which of the following is the most likely cause? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q6946811",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947180,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Dhatura poisoning</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient presents with several characteristic signs and symptoms: hot dry skin, raised temperature (hyperthermia), dilated pupils (mydriasis), slurred speech, and staggering gait. These symptoms are indicative of anticholinergic poisoning, and specifically point towards <strong>Dhatura poisoning</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dhatura (Datura) is a plant that contains tropane alkaloids, such as atropine, scopolamine, and hyoscyamine, which have strong anticholinergic effects. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These effects include: <strong>(Mnemonic DHATURA)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dryness</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of skin and mucous membranes (due to inhibition of sweat and salivary glands).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperthermia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (elevated body temperature) because of decreased sweating.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mydriasis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (Dilated pupils), leading to photophobia and blurred vision.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agitation</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachycardia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary Retention</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and loss of accommodation (difficulty focusing).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ccommodation loss &ndash; Blurred Vision </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Slurred speech</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and <strong>staggering gait</strong> can also be observed due to central nervous system effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Alcohol intoxication</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While slurred speech and a staggering gait are common in alcohol intoxication, alcohol typically causes <strong>hypothermia</strong> (lowered body temperature), not hyperthermia. Also, alcohol intoxication generally does not cause hot, dry skin or dilated pupils.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Opioid overdose</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This usually presents with pinpoint pupils (miosis), respiratory depression, and unconsciousness, not dilated pupils, hyperthermia, or dry skin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cocaine poisoning</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cocaine can cause hyperthermia and dilated pupils, but it typically results in increased activity and agitation rather than the slurred speech and staggering gait associated with Dhatura poisoning. Additionally, the dry skin is more characteristic of anticholinergic toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dhatura poisoning</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is characterized by anticholinergic symptoms such as hot dry skin, hyperthermia, dilated pupils, slurred speech, and a staggering gait, distinguishing it from other causes of altered mental status.</span></span></span></p>",
      "correct_choice_id": 228533,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6524,
      "choices": [
        {
          "id": 26065,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin E</span></p>"
        },
        {
          "id": 26066,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin K</span></p>"
        },
        {
          "id": 26067,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B6</span></p>"
        },
        {
          "id": 26068,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young patient began taking a weight loss medication that works by preventing fat absorption from food. She developed easy bruising and increased menstrual bleeding after a few weeks. Which of the following vitamins deficiency is likely to be responsible for her condition? (NEET PG 2022)</span></p>",
      "unique_key": "Q7651343",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947178,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vitamin K</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Vitamin A, D, E and K are fat soluble vitamins. Their absorption is hampered when the absorption of fat is prevented by a medication (eg Orlistat , Ezetimibe etc).</span></li><li><span style=\"font-size:12.0pt;\">Vitamin K is required for the Gamma carboxylation of Glutamic acid residues of clotting factors 2 ,7 ,9 and 10 in order to activate them. If Vitamin K is deficient due to fat malabsorption, as in the above case, then there can be bleeding manifestations in the form of easy bruising and increased menstrual bleeding in females. The Prothrombin Time (PT) will be elevated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Vitamin E:&nbsp;</strong>Vitamin E deficiency can manifest as hemolytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin B6:&nbsp;</strong>Vitamin B6 deficiency can be seen with drugs like Isoniazid, Penicillamine, Hydralazine, OCP. Patients can have peripheral neuritis, lowered seizure threshold, or convulsions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vitamin D:</strong> Vitamin D deficiency leads to the development of rickets in children and osteomalacia in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin K deficiency due to impaired fat absorption from weight loss medications can lead to bleeding manifestations such as easy bruising and increased menstrual bleeding.</span></p>",
      "correct_choice_id": 26066,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6523,
      "choices": [
        {
          "id": 26061,
          "text": "<p><span style=\"font-size:12.0pt;\">Ondansetron</span></p>"
        },
        {
          "id": 26062,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoclopramide</span></p>"
        },
        {
          "id": 26063,
          "text": "<p><span style=\"font-size:12.0pt;\">Meclizine</span></p>"
        },
        {
          "id": 26064,
          "text": "<p><span style=\"font-size:12.0pt;\">Scopolamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An antiemetic was given to a chemotherapy patient, who then developed symptoms such as acute dystonia, bradykinesia, and tremors. Which of the following medications would have resulted in these symptoms? (NEET PG 2022)</span></p>",
      "unique_key": "Q2354743",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947168,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Metoclopramide</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Metoclopramide is an antiemetic and a prokinetic drug that acts by blocking the D2 receptors. It can be given IV and it can cross the Blood brain barrier, thereby leading to D2 receptor block in the brain which can have side effects like acute dystonia, abnormal movements and drug induced Parkinsonism.</span></li><li><span style=\"font-size:12.0pt;\">In such cases, to treat them, drugs having central anticholinergic action like Benzhexol are used. They work by resorting the balance that has been disrupted by having a relative cholinergic excess in the striatum due to dopaminergic blockade.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ondansetron:&nbsp;</strong>Ondansetron is a serotonin 5-HT3 receptor antagonist. It is commonly used as an antiemetic, especially in chemotherapy-induced nausea and vomiting, but it does not cause extrapyramidal side effects like metoclopramide. Its side effect profile mainly includes headaches, constipation, and QT prolongation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Meclizine:&nbsp;</strong>Meclizine is an antihistamine with anticholinergic properties, used primarily to treat motion sickness and vertigo. It does not block dopamine receptors and therefore does not cause extrapyramidal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Scopolamine:&nbsp;</strong>Scopolamine is an anticholinergic drug used to prevent nausea and vomiting, particularly motion sickness. It works by blocking acetylcholine receptors and does not cause extrapyramidal symptoms. Its side effects include dry mouth, dizziness, and blurred vision.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metoclopramide, an antiemetic that acts by blocking D2 receptors, can cause extrapyramidal symptoms such as acute dystonia, bradykinesia, and tremors.</span></p>",
      "correct_choice_id": 26062,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76170,
      "choices": [
        {
          "id": 303553,
          "text": "<p><span style=\"font-size:16px;\">Loeffler medium&nbsp;</span></p>"
        },
        {
          "id": 303554,
          "text": "<p><span style=\"font-size:16px;\">LJ medium</span></p>"
        },
        {
          "id": 303555,
          "text": "<p><span style=\"font-size:16px;\">Thayer martin medium</span></p>"
        },
        {
          "id": 303556,
          "text": "<p><span style=\"font-size:16px;\">Macconkey agar</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A patient presents to OPD with history suggestive of tuberculosis. Culture media used commonly in India is: (FMGE JAN 2025)</span></p>",
      "unique_key": "Q7083413",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947182,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) LJ medium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In India, <strong>Lowenstein-Jensen (LJ) medium</strong> has been the traditional and most commonly used culture media for TB diagnosis. According to the transcript, under the <strong>National TB Elimination Program (NTEP)</strong>, two main culture methods are used:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">LJ medium (Lowenstein Jensen medium) - Traditional method</span></li><li><span style=\"font-size:16px;\">Automated liquid culture - Newer method (like <strong>Versatrack, BACTEC MGIT 960, BACTALERT)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Loeffler medium:</strong> Incorrect because.<strong>&nbsp;</strong>Used primarily for Corynebacterium diphtheriae isolation</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Thayer Martin medium:</strong> Incorrect because.<strong>&nbsp;</strong>This is selective for Neisseria gonorrhoeae and N. meningitidis</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Macconkey agar:</strong> Incorrect because.<strong>&nbsp;</strong>Used for differentiating lactose-fermenting from non-lactose fermenting gram-negative bacteria</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">LJ (Lowenstein Jensen) medium is the traditional and commonly used culture media for tuberculosis diagnosis in India, along with newer automated liquid culture systems under NTEP.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DC84crD.png\" width=\"859\" height=\"431\"></span></p>",
      "correct_choice_id": 303554,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80088,
      "choices": [
        {
          "id": 319068,
          "text": "<p><span style=\"font-size:12.0pt;\">Low insulin</span></p>"
        },
        {
          "id": 319069,
          "text": "<p><span style=\"font-size:12.0pt;\">Low cortisol</span></p>"
        },
        {
          "id": 319070,
          "text": "<p><span style=\"font-size:12.0pt;\">Low thyroid hormone</span></p>"
        },
        {
          "id": 319071,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated growth hormone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT an endocrine change associated with protein-energy malnutrition? (NEET PG 2015)</span></p>",
      "unique_key": "Q5197036",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947313,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: B. Low cortisol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In protein-energy malnutrition (PEM), the body undergoes specific hormonal adaptations to conserve energy and maintain essential functions. Cortisol, being a stress hormone, actually increases in malnutrition (not decreases). This elevated cortisol helps mobilize amino acids from muscle tissue, stimulates gluconeogenesis in the liver, and maintains blood glucose levels during nutritional stress—all critical survival mechanisms during starvation.</span></p><p><span style=\"font-size:12.0pt;\">The theory of adaptation in malnutrition explains these hormonal changes as the body's attempt to prioritize vital functions while reducing energy expenditure on growth and other non-essential processes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Low insulin</strong> - CORRECT finding in PEM. Insulin secretion decreases to minimize glucose uptake by peripheral tissues and maintain blood glucose for brain function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Low thyroid hormone</strong> - CORRECT finding in PEM. Thyroid hormones (T3 and T4) decrease, resulting in reduced basal metabolic rate and oxygen consumption as an energy-sparing adaptation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Elevated growth hormone</strong> - CORRECT finding in PEM. Despite increased growth hormone levels, there is peripheral resistance to its action and decreased production of insulin-like growth factor-1 (IGF-1), explaining the growth failure despite high GH levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Protein-energy malnutrition produces a characteristic endocrine profile with elevated stress hormones (cortisol), decreased anabolic hormones (insulin, thyroid hormones), and elevated but ineffective growth hormone—all serving to conserve energy and maintain vital functions during nutritional deprivation.</span></p>",
      "correct_choice_id": 319069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57291,
      "choices": [
        {
          "id": 228541,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warfarin</span></span></p>"
        },
        {
          "id": 228542,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low Molecular Weight Heparin (LMWH)</span></span></p>"
        },
        {
          "id": 228543,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apixaban</span></span></p>"
        },
        {
          "id": 228544,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fondaparinux</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman at 30 weeks of gestation is diagnosed with deep vein thrombosis (DVT). Which of the following is the most appropriate for this patient for prophylaxis? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q1768268",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947320,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Low Molecular Weight Heparin (LMWH)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During pregnancy, the choice of anticoagulant therapy is crucial due to the risks associated with both the mother and the developing fetus<strong>. Low Molecular Weight Heparin (LMWH) is the drug of choice for anticoagulation in pregnancy across all trimesters</strong>. It is preferred because it does not cross the placenta, making it safe for the fetus, and it has a lower risk of causing bleeding complications compared to other anticoagulants.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this specific case of a woman at 30 weeks of gestation diagnosed with DVT, LMWH is the most appropriate choice for prophylaxis. Warfarin, although sometimes used in the second trimester, is generally avoided due to its teratogenic effects, particularly during the first trimester and closer to delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Newer anticoagulants like Apixaban and Fondaparinux are not typically recommended during pregnancy due to insufficient evidence of safety and potential risks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Warfarin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Warfarin can be used during the second trimester up to 36 weeks if necessary. However, it is typically avoided in pregnancy because it crosses the placenta and can cause fetal complications, especially if used in the first trimester or near term.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Apixaban</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Apixaban, a newer oral anticoagulant, is generally avoided in pregnancy due to a lack of sufficient data supporting its safety for the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Fondaparinux</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Although Fondaparinux has a lower risk of heparin-induced thrombocytopenia (HIT), it is not the first-line choice during pregnancy. The data on its safety in pregnancy are limited, and therefore, LMWH is preferred.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low Molecular Weight Heparin (LMWH) is the preferred anticoagulant for both the treatment and prophylaxis of DVT during pregnancy across all trimesters due to its safety profile for both the mother and fetus.</span></span></span></p>",
      "correct_choice_id": 228542,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80912,
      "choices": [
        {
          "id": 322332,
          "text": "<p><span style=\"font-size:12.0pt;\">Cocaine</span></p>"
        },
        {
          "id": 322333,
          "text": "<p><span style=\"font-size:12.0pt;\">LSD</span></p>"
        },
        {
          "id": 322334,
          "text": "<p><span style=\"font-size:12.0pt;\">Marijuana</span></p>"
        },
        {
          "id": 322335,
          "text": "<p><span style=\"font-size:12.0pt;\">PCP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old boy involved in drug abuse reports experiencing cross-over of sensory perceptions, where he describes that sounds can be seen and colors can be heard. Which of the following substances is most likely responsible for this effect?</span><span style=\"font-size:16px;\"> (NEET PG 2016)</span></p>",
      "unique_key": "Q5945554",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947324,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: B. LSD</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The phenomenon described is synesthesia (reflex hallucinations), where stimulation in one sensory modality leads to experiences in another sensory modality (e.g., \"seeing\" sounds or \"hearing\" colors). This effect is most commonly associated with hallucinogens, particularly LSD (lysergic acid diethylamide).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Cocaine (Incorrect)</strong>: Cocaine is a stimulant that primarily causes sympathetic activation (tachycardia, hypertension, mydriasis) and euphoria. While cocaine can cause psychotic symptoms like paranoia and tactile hallucinations (\"cocaine bugs\" or formication), it does not typically cause synesthesia or sensory crossover effects.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Marijuana (Incorrect)</strong>: While cannabis (marijuana) can also cause synaesthesia or reflex hallucinations, between cannabis &amp; LSD, LSD remains the better answer as these perceptual disturbances are the characteristic feature of hallucinogen intoxication.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. PCP (Incorrect)</strong>: Phencyclidine (PCP) is a dissociative anesthetic that can cause hallucinations, detachment from reality, and severe behavioral disturbances. While it can cause various perceptual disturbances, the specific cross-sensory phenomenon of synesthesia is more characteristic of classical hallucinogens like LSD.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Synesthesia (the crossing or merging of sensory modalities) is a characteristic effect of hallucinogenic drugs, particularly LSD. This perceptual phenomenon, where stimuli in one sensory domain trigger experiences in another (like seeing sounds or tasting colors), is part of the profound alterations in consciousness that make LSD and similar substances powerful hallucinogens.</span></p>",
      "correct_choice_id": 322333,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6511,
      "choices": [
        {
          "id": 26013,
          "text": "<p><span style=\"font-size:12.0pt;\">Teriparatide can be given along with bisphosphonates.</span></p>"
        },
        {
          "id": 26014,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisphosphonates are not given for more than a year</span></p>"
        },
        {
          "id": 26015,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium requirement is 1200 mg per day</span></p>"
        },
        {
          "id": 26016,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral vitamin D3 is given along with oral calcium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old postmenopausal female patient with a history of Colle's fracture comes to the outpatient department complaining of lower back pain. After undergoing a bone density test, her T score is found to be -2.5. Which of the following statements about the management of her condition is incorrect? (NEET PG 2021)</span></p>",
      "unique_key": "Q6183526",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947327,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Bisphosphonates are not given for more than a year</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This question deals with osteoporotic post-menopausal female, who has a history of fracture as well.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bisphosphonates which act by inhibiting the bone resorption by the osteoclasts form the first line of treatment in this patient. Bisphosphonates are DOC for Osteoporosis (Steroid induced, post-menopausal and due to any reason). These are indicated for 5 years and then a drug holiday of 2-3 years is given to avoid adverse effects (increased risk of bone fractures and osteonecrosis of mandible). These can be repeated for another 5 years after drug holiday.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Teriparatide can be given along with bisphosphonates: </strong>Teriparatide is a parathyroid hormone analog that stimulates bone formation by increasing osteoblast activity. It is particularly useful in patients with severe osteoporosis and a history of fractures. It can be started before bisphosphonates in certain cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Calcium requirement is 1200 mg per day: </strong>The recommended daily intake of calcium for postmenopausal women is around 1200 mg. This helps maintain bone density and prevent further bone loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Oral vitamin D3 is given along with oral calcium: </strong>Supplementation with oral vitamin D3 (cholecalciferol) along with calcium is essential to ensure proper calcium absorption and to maintain bone health. The recommended dose of vitamin D3 is typically around 800 IU per day.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bisphosphonates are recommended for up to 5 years, not just one year, in the treatment of osteoporosis in postmenopausal women.</span></p>",
      "correct_choice_id": 26014,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6508,
      "choices": [
        {
          "id": 26001,
          "text": "<p><span style=\"font-size:12.0pt;\">Tablet alprazolam 0.5 mg once a day before bedtime for 7 days</span></p>"
        },
        {
          "id": 26002,
          "text": "<p><span style=\"font-size:12.0pt;\">Tablet alprazolam 0.5 mg HS for 7 days</span></p>"
        },
        {
          "id": 26003,
          "text": "<p><span style=\"font-size:12.0pt;\">Tablet alprazolam 500 mcg one tablet OD for 7 days</span></p>"
        },
        {
          "id": 26004,
          "text": "<p><span style=\"font-size:12.0pt;\">Tablet alprazolam ½ mg tablet HS daily</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">As an Indian medical intern, which of the following is the correct format for prescription of alprazolam? (NEET PG 2021)</span></p>",
      "unique_key": "Q8135015",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947177,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tablet alprazolam 0.5 mg once a day before bedtime for 7 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>IMPORTANT POINTS REGARDING PRESCRIPTION WRITING:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Prescription is invalid without date and signature of the doctor.</span></li><li><span style=\"font-size:12.0pt;\">Drug name should never been written in abbreviation form (e.g. never write PCM for paracetamol).</span></li><li><span style=\"font-size:12.0pt;\">Abbreviations like OD, BD, HS etc should not be used in prescription.</span></li><li><span style=\"font-size:12.0pt;\">Leading zeros should always be mentioned (e.g. 0.5 mg is correct but .5 mg is incorrect)</span></li><li><span style=\"font-size:12.0pt;\">Trail zeros should never be written (e.g. 5 mg is correct but 5.0 is incorrect).</span></li><li><span style=\"font-size:12.0pt;\">Microgram should be written as mcg not as µg.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When writing a prescription, always avoid abbreviations for dosage instructions, use clear and complete language, include leading zeros for dosages less than one, and avoid trailing zeros. The correct format ensures clarity and safety for the patient.</span></p>",
      "correct_choice_id": 26001,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76164,
      "choices": [
        {
          "id": 303529,
          "text": "<p><span style=\"font-size:16px;\">Weight for age</span></p>"
        },
        {
          "id": 303530,
          "text": "<p><span style=\"font-size:16px;\">Weight for height</span></p>"
        },
        {
          "id": 303531,
          "text": "<p><span style=\"font-size:16px;\">Height for age</span></p>"
        },
        {
          "id": 303532,
          "text": "<p><span style=\"font-size:16px;\">Head circumference</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Best indicator for chronic malnutrition in children is: (FMGE JAN 2025)</span></p>",
      "unique_key": "Q4653562",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947162,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Height for age</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Height for age is the <strong>best indicator</strong> of <strong>chronic malnutrition</strong> in children. When height for age is low, it indicates <strong>stunting</strong>, which develops over a long period due to <strong>chronic nutritional</strong> <strong>deficiency</strong>. This is because:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Height takes a longer time to be affected by nutritional deficiency</span></li><li><span style=\"font-size:16px;\">Once affected, height also takes longer to recover</span></li><li><span style=\"font-size:16px;\">Therefore, low <strong>height for age (stunting</strong>) reflects long-term or chronic nutritional deficiency</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Weight for age:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Indicates<strong> underweight</strong> status</span></li><li><span style=\"font-size:16px;\">Reflects <strong>acute on chronic malnutrition</strong></span></li><li><span style=\"font-size:16px;\">Can change relatively quickly with nutritional status</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Weight for height:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Indicates <strong>wasting</strong></span></li><li><span style=\"font-size:16px;\">Reflects <strong>acute malnutrition</strong></span></li><li><span style=\"font-size:16px;\">Changes rapidly with current nutritional status</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Head circumference:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Not a primary indicator for malnutrition</span></li><li><span style=\"font-size:16px;\">More relevant for <strong>neurological development assessment</strong></span></li><li><span style=\"font-size:16px;\">Does not specifically reflect nutritional status</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Height for age is the best indicator of <strong>chronic malnutrition</strong> in children, with low values indicating stunting, while weight for height indicates acute malnutrition (wasting) and weight for age indicates acute on chronic malnutrition (underweight).</span></p>",
      "correct_choice_id": 303531,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80909,
      "choices": [
        {
          "id": 322320,
          "text": "<p><span style=\"font-size:12.0pt;\">Response Prevention</span></p>"
        },
        {
          "id": 322321,
          "text": "<p><span style=\"font-size:12.0pt;\">Exposure</span></p>"
        },
        {
          "id": 322322,
          "text": "<p><span style=\"font-size:12.0pt;\">Thought Stopping</span></p>"
        },
        {
          "id": 322323,
          "text": "<p><span style=\"font-size:12.0pt;\">Desensitization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman compulsively washes her hands at least 40 times per day without any logical reason. Which of the following Cognitive Behavioral Therapy (CBT) techniques is most appropriate for her treatment?</span><span style=\"font-size:16px;\"> (NEET PG 2016)</span></p>",
      "unique_key": "Q1075929",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947184,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: A. Response Prevention</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Response Prevention is the most appropriate technique for treating compulsive hand washing, which is a classic symptom of OCD. In this case, the woman engages in repetitive handwashing (compulsion) likely in response to obsessive thoughts about contamination. Response Prevention involves preventing the person from performing the compulsive behavior (handwashing) when they feel the urge. This breaks the reinforcement cycle where the anxiety reduction from performing the compulsion reinforces the behavior. When used together with Exposure therapy, it forms \"Exposure and Response Prevention\" (ERP), which is the first-line psychotherapeutic treatment for OCD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option B. Exposure (Incorrect)</strong>: While Exposure is an important component of treating OCD, it is typically used in conjunction with Response Prevention. Exposure alone (having the patient confront the feared contaminant) without preventing the compulsive response would not effectively treat the condition as the patient would continue to use handwashing to reduce anxiety. Hence, if we have to pick between exposure and response prevention, the response prevention becomes the better answer.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Thought Stopping (Incorrect)</strong>: Thought stopping is a technique where the patient attempts to interrupt unwanted thoughts, often using distraction or verbal commands. While sometimes used in cognitive therapy, it's not considered highly effective for OCD treatment and is not the first-line approach for compulsive behaviors.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Desensitization (Incorrect)</strong>: Systematic desensitization involves gradually exposing patients to anxiety-provoking stimuli while they are in a relaxed state. While useful for specific phobias, it is not the primary technique for treating compulsive behaviors in OCD. The technique doesn't address the response component of the OCD cycle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Exposure and Response Prevention (ERP) is the treatment of choice for OCD, including compulsive hand washing. Response Prevention specifically targets the compulsive behavior by preventing the ritualistic response, while Exposure targets the obsessional fears. Together they break the OCD cycle of obsessions leading to anxiety, followed by compulsions that temporarily reduce anxiety but ultimately reinforce the behavior.</span></p>",
      "correct_choice_id": 322320,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44800,
      "choices": [
        {
          "id": 178847,
          "text": "<p><span style=\"font-size:12pt;\">Pioglitazone</span></p>"
        },
        {
          "id": 178848,
          "text": "<p><span style=\"font-size:12pt;\">Pramlintide</span></p>"
        },
        {
          "id": 178849,
          "text": "<p><span style=\"font-size:12pt;\">Glimepiride</span></p>"
        },
        {
          "id": 178850,
          "text": "<p><span style=\"font-size:12pt;\">Metformin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following anti-diabetic drug is associated with unexplained diarrhea? (</span>INICET May 2024)</p>",
      "unique_key": "Q2470630",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947316,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Metformin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity.&nbsp;</span></li><li><span style=\"font-size:12pt;\">It is well known to cause gastrointestinal side effects, including diarrhea, nausea, and abdominal discomfort, particularly when first starting the medication or when the dose is increased.&nbsp;</span></li><li><span style=\"font-size:12pt;\">Diarrhea is one of the most common side effects of metformin and can sometimes be severe or persistent.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Pioglitazone</strong>: Pioglitazone is a thiazolidinedione that improves insulin sensitivity. It is not commonly associated with diarrhea. Its common side effects include weight gain, edema, and an increased risk of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Pramlintide</strong>: Pramlintide is an amylin analog used as an adjunct treatment for diabetes. It slows gastric emptying and promotes satiety but is not typically associated with diarrhea. Nausea is a more common gastrointestinal side effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Glimepiride</strong>: Glimepiride is a sulfonylurea that increases insulin secretion from the pancreas. It is not known to cause diarrhea. Hypoglycemia is its most significant side effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, metformin is the anti-diabetic drug most commonly associated with unexplained diarrhea. The patient's symptoms are likely related to metformin use.</span></p>",
      "correct_choice_id": 178850,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44831,
      "choices": [
        {
          "id": 178971,
          "text": "<p><span style=\"font-size:12pt;\">Dravet Syndrome</span></p>"
        },
        {
          "id": 178972,
          "text": "<p><span style=\"font-size:12pt;\">Tuberous sclerosis</span></p>"
        },
        {
          "id": 178973,
          "text": "<p><span style=\"font-size:12pt;\">Rett syndrome</span></p>"
        },
        {
          "id": 178974,
          "text": "<p><span style=\"font-size:12pt;\">Lennox Gastaut syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Cannabinoids are not approved for treatment of (</span>INICET May 2024)</p>",
      "unique_key": "Q3673868",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947326,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Rett syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Cannabinoids, including cannabidiol (CBD), are not currently approved for the treatment of Rett syndrome.&nbsp;</span></li><li><span style=\"font-size:12pt;\">Rett syndrome is a rare genetic neurological disorder, and while there is ongoing research into potential treatments, cannabinoids are not among the approved therapies for this condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Dravet Syndrome</strong>: Cannabidiol (CBD) is approved for the treatment of Dravet Syndrome, a severe form of epilepsy. It is used to reduce the frequency of seizures in patients with this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Tuberous sclerosis</strong>: Cannabidiol (CBD) is also approved for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC). It has been shown to reduce seizure frequency in patients with TSC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Lennox Gastaut syndrome</strong>: Cannabidiol (CBD) is approved for the treatment of Lennox-Gastaut Syndrome, another severe form of epilepsy. It is used to help reduce the frequency of seizures in patients with this syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, cannabinoids, specifically cannabidiol (CBD), are not approved for the treatment of Rett syndrome, whereas they are approved for use in Dravet Syndrome, Tuberous Sclerosis, and Lennox-Gastaut Syndrome.</span></p>",
      "correct_choice_id": 178973,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20914,
      "choices": [
        {
          "id": 83620,
          "text": "<p><span style=\"font-size:12.0pt;\">Probenecid</span></p>"
        },
        {
          "id": 83621,
          "text": "<p><span style=\"font-size:12.0pt;\">Colchicine</span></p>"
        },
        {
          "id": 83622,
          "text": "<p><span style=\"font-size:12.0pt;\">Diclofenac</span></p>"
        },
        {
          "id": 83623,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with recurrent attacks of gout was started on a therapy that inhibits the synthesis of uric acid. His symptoms were relieved after therapy. Identify the drug he was prescribed? (NEET PG 2023)</span></p>",
      "unique_key": "Q5635837",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947319,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Allopurinol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Allopurinol is a competitive inhibitor of the xanthine oxidase enzyme. It decreases the production of uric acid, therefore useful in cases of hyperuricemia and chronic gout.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-171027.png\" alt=\"\" width=\"1000\" height=\"507\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Probenecid</strong>: Probenecid is a uricosuric agent that promotes the excretion of uric acids. Plenty of fluids are given to avoid urate calculi formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Colchicine</strong></span><span style=\"font-size:12pt;\">: Colchicine is Inhibit granulocyte migration and the release of glycoprotein from neutrophils. Used in Gout, Cirrhosis, Acute Mediterranean Fever, Sarcoidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Diclofenac</strong></span><span style=\"font-size:12pt;\">: Diclofenac is a Non-Selective COX inhibitor having analgesic, antipyretic, and anti-inflammatory property. A/E – Peptic ulcer disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Allopurinol</strong> is the drug of choice for reducing uric acid synthesis in patients with chronic gout by inhibiting the xanthine oxidase enzyme. It effectively lowers serum and urinary uric acid levels, thereby preventing gout attacks.</span></p>",
      "correct_choice_id": 83623,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48837,
      "choices": [
        {
          "id": 194931,
          "text": "<p><span style=\"font-size:12.0pt;\">LGV</span></p>"
        },
        {
          "id": 194932,
          "text": "<p><span style=\"font-size:12.0pt;\">Chancroid</span></p>"
        },
        {
          "id": 194933,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes Genitalis</span></p>"
        },
        {
          "id": 194934,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary Syphilis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A patient with unilateral, unilocular suppurating bubo and a single sinus tract is observed to have a primary genital ulcer. The likely diagnosis is: (NEET PG 2017)</span></p>",
      "unique_key": "Q4093716",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947325,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chancroid</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Chancroid is characterized by <strong>painful genital ulcers</strong> accompanied by unilateral <strong>suppurative (pus-filled) inguinal lymphadenopathy (bubo)</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture43_TMCp8lX.png\" width=\"312\" height=\"393\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Concomitant genital ulcer</strong> is seen in chancroid.</span></li><li><span style=\"font-size:12.0pt;\">The key connection here is the presence of both a primary genital ulcer and suppurating bubo with <strong>sinus tract</strong> formation.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Chancroid is caused by <strong>Haemophilus ducreyi</strong> and has an incubation period of 3-5 days.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">The genital ulcer in chancroid is s<strong>oft, tender, with necrotic base and ragged undermined edges that bleeds on touch.</strong>&nbsp;</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture44_RT2Pldi.png\" width=\"370\" height=\"498\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. LGV (Lymphogranuloma Venereum):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Incorrect because in LGV, the primary <strong>genital ulcer is transient&nbsp;</strong>and often goes <strong>unnoticed or has already healed by the time the bubo develops.</strong>&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">The question explicitly mentions the presence of both the <strong>ulcer and bubo simultaneously,</strong> which is characteristic of chancroid rather than LGV.</span></li><li><span style=\"font-size:12.0pt;\">LGV buboes also tend to exhibit the <strong>\"groove sign\"</strong> due to involvement of both inguinal and femoral nodes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture45.png\" width=\"358\" height=\"348\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Herpes Genitalis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Incorrect because while herpes causes<strong> painful genital ulcers</strong> (typically multiple grouped <strong>vesicles</strong> that rupture to form ulcers with <strong>polycyclic margins</strong>), it does <strong>not cause</strong> suppurative <strong>bubo</strong> formation with sinus tracts.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Herpes may cause<strong> bilateral tender lymphadenopathy</strong>, but not the formation of buboes that suppurate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Primary Syphilis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Incorrect because primary syphilis causes a <strong>painless, indurated, clean-based ulcer (chancre) with non-suppurative bilateral lymphadenopathy</strong>.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">The lymph nodes in primary syphilis are typically described as <strong>\"shotty\"&nbsp;</strong>and do not form suppurative buboes or sinus tracts.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">The lymphadenopathy is also <strong>usually bilateral</strong> rather than unilateral.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The combination of a primary genital ulcer with a <strong>concurrent unilateral suppurating bubo that forms a sinus tract is highly characteristic of chancroid</strong>, distinguishing it from other sexually transmitted infections like <strong>LGV (where the primary lesion is often absent by the time buboes appear)</strong>, <strong>herpes (which doesn't cause suppurative buboes)</strong>, and <strong>syphilis (which causes painless, non-suppurating lymphadenopathy).</strong></span></li></ul>",
      "correct_choice_id": 194932,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55639,
      "choices": [
        {
          "id": 222001,
          "text": "<p><span style=\"font-size:12.0pt;\">Type I</span></p>"
        },
        {
          "id": 222002,
          "text": "<p><span style=\"font-size:12.0pt;\">Type II</span></p>"
        },
        {
          "id": 222003,
          "text": "<p><span style=\"font-size:12.0pt;\">Type III</span></p>"
        },
        {
          "id": 222004,
          "text": "<p><span style=\"font-size:12.0pt;\">Type IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the type of injury shown in the following image.<strong>&nbsp;</strong>(FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-113001.jpeg\" alt=\"\" width=\"300\" height=\"281\"></span></p>",
      "unique_key": "Q3510148",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947171,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Type II</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The <strong>Salter-Harris classification system</strong> is used to describe fractures involving the growth plate (physis) in children.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>The types range from I to V, with increasing severity:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Type I:</strong> Slip or separation of the growth plate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type II:</strong> Fracture that involves a part of the metaphysis and the growth plate. This is the most common type and is also known as the <strong>Thurston-Holland sign</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type III:</strong> Fracture through the growth plate and epiphysis, involving the joint surface, causing epiphyseal split.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type IV:</strong> Fracture through the growth plate, metaphysis, and epiphysis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type V:</strong> Compression/crush injury to the growth plate with initially normal x-ray.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20105951.jpg\" width=\"620\" height=\"429\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">In the provided image, the fracture depicted involves both the growth plate and a part of the metaphysis, which classifies it as a <strong>Type II injury</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Remember:&nbsp;</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">MC type is Type II.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Location of Epiphyseal Injuries</strong>: When it comes to epiphyseal injuries, particularly in pediatric cases, these injuries typically occur through the <strong>zone of hypertrophy</strong> of the growth plate. This zone is one of the layers of the growth plate where chondrocytes mature and enlarge before the end of the bone lengthens.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option Type I:</strong> Involves only the growth plate without extending into the metaphysis or epiphysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option Type III:</strong> Involves the growth plate and the epiphysis, extending into the joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option Type IV:</strong> Involves the growth plate, metaphysis, and epiphysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The given image shows the Type II Salter-Harris physeal injury in children.</span></li><li><span style=\"font-size:12.0pt;\">A Type II Salter-Harris fracture involves both the growth plate and a part of the metaphysis and is the most common type of growth plate fracture.</span></li></ul>",
      "correct_choice_id": 222002,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44790,
      "choices": [
        {
          "id": 178807,
          "text": "<p><span style=\"font-size:12pt;\">SGLT2 inhibitors</span></p>"
        },
        {
          "id": 178808,
          "text": "<p><span style=\"font-size:12pt;\">Finerenone</span></p>"
        },
        {
          "id": 178809,
          "text": "<p><span style=\"font-size:12pt;\">Hydrochlorthiazide</span></p>"
        },
        {
          "id": 178810,
          "text": "<p><span style=\"font-size:12.0pt;\">Angiotensin receptor blockers</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 55-year-old patient presents to the clinic with a history of hyperglycemia and has had positive urine glucose tests on two separate occasions in the last six months. The patient has been diagnosed with type 2 diabetes mellitus. The physician is considering various medications to manage the patient's condition and prevent potential complications, including renal involvement. Which of the following drugs will not delay renal involvement? (</span>INICET May 2024)</p>",
      "unique_key": "Q1724241",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947166,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Hydrochlorothiazide</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Hydrochlorothiazide is a thiazide diuretic used to treat hypertension.&nbsp;</span></li><li><span style=\"font-size:12pt;\">While effective at lowering blood pressure, it does not have specific renal protective effects and may not delay the progression of renal disease in diabetic patients.&nbsp;</span></li><li><span style=\"font-size:12pt;\">In fact, in some cases, thiazide diuretics can increase the risk of developing hyperglycemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>SGLT2 inhibitors</strong>: SGLT2 inhibitors (e.g., canagliflozin, dapagliflozin) are a class of medications used to lower blood sugar in patients with type 2 diabetes. They work by promoting glucose excretion through the urine. Importantly, SGLT2 inhibitors have been shown to provide renal protection and delay the progression of diabetic kidney disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Finerenone: </strong>It is a non-steroidal mineralocorticoid receptor antagonist that reduces inflammation and fibrosis in the kidneys. Clinical trials have demonstrated that finerenone can reduce the risk of kidney disease progression in patients with chronic kidney disease and type 2 diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Angiotensin receptor blockers (ARBs)</strong>: ARBs (e.g., losartan, valsartan) are another class of medications used to manage hypertension and heart failure. Like ACE inhibitors, ARBs have been shown to provide renal protection and delay the progression of diabetic nephropathy by reducing proteinuria and lowering intraglomerular pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In summary, while SGLT2 inhibitors, ACE inhibitors, and ARBs have renal protective properties and can help delay renal involvement in diabetic patients, hydrochlorothiazide does not have these specific protective effects and is the correct answer in this context.</span></p>",
      "correct_choice_id": 178809,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76174,
      "choices": [
        {
          "id": 303569,
          "text": "<p><span style=\"font-size:16px;\">10%</span></p>"
        },
        {
          "id": 303570,
          "text": "<p><span style=\"font-size:16px;\">33%</span></p>"
        },
        {
          "id": 303571,
          "text": "<p><span style=\"font-size:16px;\">50%</span></p>"
        },
        {
          "id": 303572,
          "text": "<p><span style=\"font-size:16px;\">66%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">In a class trip there were 75 camper school students, of which 50 had been immunized for Measles previously. During the trip, a child developed Measles. Subsequently, upon returning home, 12 more children developed Measles. Calculate the Secondary attack rate for Measles. (FMGE JAN 2025)</span></p>",
      "unique_key": "Q1316748",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947322,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans. C) 50%</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Secondary Attack Rate (SAR) is calculated using the formula:&nbsp;</span></p><p style=\"margin-left:0cm;\"><br><span style=\"font-size:16px;\"><strong>SAR&nbsp;</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ZGfCsCx.png\" width=\"477\" height=\"67\"></strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Total students = 75</span></li><li><span style=\"font-size:16px;\">Previously immunized = 50 (these are immune and not susceptible)</span></li><li><span style=\"font-size:16px;\">Susceptible students initially = 75 - 50 = 25</span></li><li><span style=\"font-size:16px;\">One student developed measles first (primary case)</span></li><li><span style=\"font-size:16px;\">Therefore, remaining susceptibles = 24</span></li><li><span style=\"font-size:16px;\">Secondary cases = 12</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Applying the formula: SAR = (12/24) × 100 = 50%</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">The primary case is excluded both from <strong>numerator and denominator as they cannot be a secondary case.</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Secondary Attack Rate (SAR) is the number of cases occurring within the incubation period following exposure to a primary case, expressed as a percentage of the total number of exposed susceptible persons. The primary case should be excluded from both numerator and denominator.</span></p><p style=\"margin-left:0cm;\"><br><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_AU6uEy3.png\" width=\"515\" height=\"73\"></span></p>",
      "correct_choice_id": 303571,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80900,
      "choices": [
        {
          "id": 322284,
          "text": "<p><span style=\"font-size:12.0pt;\">Fear of places from which escape is difficult</span></p>"
        },
        {
          "id": 322285,
          "text": "<p><span style=\"font-size:12.0pt;\">Fear of heights</span></p>"
        },
        {
          "id": 322286,
          "text": "<p><span style=\"font-size:12.0pt;\">Fear of open spaces</span></p>"
        },
        {
          "id": 322287,
          "text": "<p><span style=\"font-size:12.0pt;\">Fear of crowded places</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following may be termed as Agoraphobia, except:</span><span style=\"font-size:16px;\"> (NEET PG 2015)</span></p>",
      "unique_key": "Q6918115",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947183,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: B. Fear of heights</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Agoraphobia is specifically defined as fear of places from which escape might be difficult. The fear of heights (acrophobia) is a specific phobia and not a component of agoraphobia. Agoraphobia includes fears related to situations where escape might be challenging, embarrassing, or help may not be available if panic-like symptoms occur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Fear of places from where escape is difficult (Incorrect)</strong>: This is the core definition of agoraphobia. People with agoraphobia fear situations where they feel trapped, helpless, or embarrassed.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Fear of open spaces (Incorrect)</strong>: This is included in the definition of agoraphobia.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Fear of crowded places (Incorrect)</strong>: Fear of crowded places is a characteristic manifestation of agoraphobia. Crowded places may trigger anxiety due to perceived difficulty in escaping or reaching help if needed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Agoraphobia is characterized by fear of situations where escape might be difficult, help might not be available, or where panic attacks might occur. It commonly includes fears of open spaces, enclosed places, crowds, public transportation, and being outside alone. Specific phobias like acrophobia (fear of heights) are distinct from agoraphobia and classified separately as specific phobias.</span></p>",
      "correct_choice_id": 322285,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45137,
      "choices": [
        {
          "id": 180195,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of Circle of Hebra lesions</span></p>"
        },
        {
          "id": 180196,
          "text": "<p><span style=\"font-size:12.0pt;\">Scalp and face are spared in infants</span></p>"
        },
        {
          "id": 180197,
          "text": "<p><span style=\"font-size:12.0pt;\">Norwegian scabies is the most severe form</span></p>"
        },
        {
          "id": 180198,
          "text": "<p><span style=\"font-size:12.0pt;\">Burrows are found in the stratum corneum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is incorrect regarding scabies? (NEET PG 2017)</span></p>",
      "unique_key": "Q7881576",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947185,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Scalp and face are spared in infants</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The statement that \"Scalp and face are spared in infants\" is incorrect regarding scabies.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">In <strong>infants and young children</strong>, scabies frequently involves the <strong>scalp, face, neck, and even the palms and soles.</strong></span></li><li><span style=\"font-size:12.0pt;\">This is in contrast to adults, where the head and neck are usually spared (<strong>except in crusted/Norwegian scabies).&nbsp;</strong></span></li><li><span style=\"font-size:12.0pt;\">The predilection for <strong>head and face</strong> involvement in <strong>infants</strong> is an important diagnostic feature of infantile scabies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-05%20123311.png\" width=\"1004\" height=\"329\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Presence of Circle of Hebra lesions :</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Circle of Hebra refers to the <strong>characteristic distribution of scabies</strong> lesions around the umbilicus in a circular pattern.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">This is a recognized feature of scabies and helps in clinical diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Norwegian scabies is the most severe form:</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Norwegian scabies (also called <strong>crusted scabies</strong>) is indeed the <strong>most severe form of scabies.</strong>&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">It is characterized by massive <strong>hyperinfestation&nbsp;</strong>with <strong>thousands to millions of mites,&nbsp;</strong>extensive scaling, <strong>crusting, and hyperkeratosis.</strong>&nbsp;</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture39.png\" width=\"318\" height=\"376\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It typically occurs in i<strong>mmunocompromised</strong> individuals, the elderly, or those with <strong>neurological disorders.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Burrows are found in the stratum corneum:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The female Sarcoptes scabiei mite creates burrows specifically within the stratum corneum (the <strong>outermost layer of the epidermis</strong>).&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">These burrows appear as <strong>thin, grayish, slightly raised, linear or curved lines</strong> and are pathognomonic for scabies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Unlike in <strong>adults</strong> where the <strong>head and neck</strong> are typically <strong>spared</strong>, scabies in <strong>infants and young children</strong> commonly involves the <strong>scalp, face, and neck areas</strong>, making this an important distinguishing feature for diagnosing scabies in different age groups.</span></li></ul>",
      "correct_choice_id": 180196,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45135,
      "choices": [
        {
          "id": 180187,
          "text": "<p><span style=\"font-size:12.0pt;\">Tinea capitis</span></p>"
        },
        {
          "id": 180188,
          "text": "<p><span style=\"font-size:12.0pt;\">Tinea barbae</span></p>"
        },
        {
          "id": 180189,
          "text": "<p><span style=\"font-size:12.0pt;\">Tinea cruris</span></p>"
        },
        {
          "id": 180190,
          "text": "<p><span style=\"font-size:12.0pt;\">Tinea unguium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">What is the most accurate description of Eczema marginatum? (NEET PG 2017)</span></p>",
      "unique_key": "Q1116586",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947175,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Tinea cruris</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Eczema marginatum</strong> is another name for <strong>Tinea cruris</strong>, which is a <strong>dermatophyte infection&nbsp;</strong>of the <strong>groin area</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:560/418;width:72.4%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/27.png\" width=\"560\" height=\"418\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">It is also colloquially referred to as <strong>\"jock itch\" or \"dhobi itch.</strong>\"</span></li><li><span style=\"font-size:12.0pt;\">Tinea cruris presents as an annular, sharply demarcated plaque with <strong>peripheral scaling, inner aspects of the thighs.&nbsp;</strong></span></li><li><span style=\"font-size:12.0pt;\">The infection expands centrifugally with <strong>central clearing</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tinea capitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Tinea capitis refers to a <strong>dermatophyte infection of the scalp and hair</strong>, not the groin.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">It typically manifests as <strong>patches of hair loss</strong> with scaling and can present as <strong>black dot, gray patch, kerion, or favus</strong> variants depending on the causative organism and host immune response.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Tinea barbae:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Tinea barbae refers to a <strong>fungal infection</strong> of the <strong>beard area</strong> in men.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">It is not the same as Eczema marginatum, which affects the groin area.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Tinea barbae involves the coarse <strong>terminal hair</strong> of the beard and can cause follicular inflammation.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/28_A3zKtzS.png\" width=\"572\" height=\"428\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tinea unguium:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Tinea unguium refers to a <strong>dermatophyte infection</strong> of the <strong>nail plate.&nbsp;</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img class=\"image_resized\" style=\"aspect-ratio:352/249;width:61.95%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/105.png\" width=\"352\" height=\"249\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">It presents with <strong>discoloration, thickening, and crumbling</strong> of the nail plate with subungual hyperkeratosis.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Eczema marginatum is synonymous with <strong>Tinea cruris (fungal infection of the groin),</strong> characterized by annular, well-demarcated plaques with active margins showing <strong>scaling and inflammation</strong>, most commonly affecting the <strong>inner thighs and groin area.</strong></span></li></ul>",
      "correct_choice_id": 180189,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80898,
      "choices": [
        {
          "id": 322276,
          "text": "<p><span style=\"font-size:12.0pt;\">Barbiturates</span></p>"
        },
        {
          "id": 322277,
          "text": "<p><span style=\"font-size:12.0pt;\">Heroin</span></p>"
        },
        {
          "id": 322278,
          "text": "<p><span style=\"font-size:12.0pt;\">Cannabis</span></p>"
        },
        {
          "id": 322279,
          "text": "<p><span style=\"font-size:12.0pt;\">Magic Mushrooms</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Long-term drug abuse with which of the following is associated with an increased risk of developing Schizophrenia?</span><span style=\"font-size:16px;\"> (NEET PG 2015)</span></p>",
      "unique_key": "Q6813781",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947163,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: C. Cannabis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Long-term cannabis use has been associated with an increased risk of developing schizophrenia. Regular cannabis use, especially during adolescence when the brain is still developing, can significantly increase the risk of developing psychotic disorders including schizophrenia in predisposed individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Barbiturates (Incorrect)</strong>: While barbiturates can cause various adverse effects including dependence and cognitive impairment, they have not been specifically linked to increased risk of developing schizophrenia.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Heroin (Incorrect)</strong>: Heroin is an opioid that can lead to severe dependence and various health problems, but it is not specifically associated with increasing the risk of developing schizophrenia.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Magic Mushrooms (Incorrect)</strong>: Magic mushrooms contain psilocybin, a hallucinogen that can cause short-term psychotic-like experiences during intoxication. However, unlike cannabis, they have not been consistently linked to increased risk of developing chronic schizophrenia.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cannabis use, particularly during adolescence and young adulthood, is a recognized environmental risk factor for developing schizophrenia in vulnerable individuals. The risk appears to be dose-dependent and may involve interactions with genetic predisposition.</span></p>",
      "correct_choice_id": 322278,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55641,
      "choices": [
        {
          "id": 222009,
          "text": "<p><span style=\"font-size:12.0pt;\">Enchondroma</span></p>"
        },
        {
          "id": 222010,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteosarcoma</span></p>"
        },
        {
          "id": 222011,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteomyelitis</span></p>"
        },
        {
          "id": 222012,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteochondroma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 17-year-old boy presents with growth on talus as seen on foot x-ray. What is the likely diagnosis? (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20110005.jpg\" width=\"636\" height=\"449\"></p>",
      "unique_key": "Q2997848",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947181,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Osteochondroma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Osteochondroma is a common <strong>benign bone tumor</strong> that typically presents as a <strong>growth on the bone with a cartilage cap</strong>.&nbsp;</span></li><li><span style=\"font-size:16px;\">In this case, the boy has a growth on the talus, which is characteristic of osteochondroma.</span></li><li><span style=\"font-size:16px;\"><strong>X-ray Findings</strong>: On x-ray, osteochondroma appears as a bone growth projecting from the surface, often with a <strong>cartilaginous cap</strong> that is <strong>not visible on the x-ray</strong> itself since cartilage is radiolucent.</span></li><li><span style=\"font-size:16px;\"><strong>Presentation</strong>: Patients often notice a <strong>palpable mass</strong>, which feels larger than what is seen on the x-ray due to the cartilage component (as radiolucent).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Enchondroma</strong>: This is a benign cartilaginous tumor that occurs inside the bone (endosteal). It is more common in small bones of the hands and feet and does not present as an external growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20110019.jpg\" width=\"574\" height=\"367\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Osteosarcoma</strong>: This is a malignant bone tumor typically found in the metaphyses of long bones, such as around the knee. It presents as a destructive bone lesion with a periosteal reaction, often not seen in the talus.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20110033.jpg\" width=\"303\" height=\"440\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Osteomyelitis</strong>: This is an infection of the bone that leads to inflammation. It usually shows a solid periosteal reaction or lytic cavities on x-ray and does not present as a growth.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">The given x-ray image shows growth in the talus which is characteristic of osteochondroma of the talus bone.&nbsp;</span></li><li><span style=\"font-size:16px;\">Osteochondroma is a benign bone tumor presenting as a palpable growth with a cartilaginous cap, most often found in young adults, and visible on x-ray as a bony projection.</span></li></ul>",
      "correct_choice_id": 222012,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55637,
      "choices": [
        {
          "id": 221993,
          "text": "<p><span style=\"font-size:12.0pt;\">Bennet’s fracture</span></p>"
        },
        {
          "id": 221994,
          "text": "<p><span style=\"font-size:12.0pt;\">Scaphoid fracture</span></p>"
        },
        {
          "id": 221995,
          "text": "<p><span style=\"font-size:12.0pt;\">Rolando fracture</span></p>"
        },
        {
          "id": 221996,
          "text": "<p><span style=\"font-size:12.0pt;\">Colles fracture</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Patient had a fall on Outstretched hand. He presented with Fracture and displacement of Base of 1st metacarpal. This fracture is known as: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q2472057",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947161,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Bennet’s fracture&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">A Bennett's fracture is an <strong>intra-articular fracture</strong> at the <strong>base of the first metacarpal</strong> bone, which is associated with <strong>displacement</strong> due to the <strong>pull of the abductor pollicis longus</strong> muscle.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20105840.jpg\" width=\"315\" height=\"358\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This type of fracture typically occurs when a person falls on an outstretched hand (<strong>FOOSH injury</strong>).&nbsp;</span></li><li><span style=\"font-size:16px;\">The mechanism of injury and the <strong>specific displacement</strong> due to muscle pull are characteristic of Bennett's fracture.</span></li><li><span style=\"font-size:16px;\">The&nbsp;shaft of the metacarpal is <strong>laterally dislocated</strong> by the <strong>unopposedpull of the abductor pollicis longus.&nbsp;</strong></span></li><li><span style=\"font-size:16px;\">The <strong>medial projection of the metacarpal base</strong> on which the volar oblique ligament attaches <strong>remains in place.&nbsp;</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Scaphoid fracture:</strong> A scaphoid fracture is common in young adults after a fall on an outstretched hand, but it involves the scaphoid bone in the wrist, not the base of the first metacarpal.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20105852.jpg\" width=\"554\" height=\"383\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Rolando fracture:</strong> This is also an intra-articular fracture at the base of the first metacarpal (T or Y) but involves comminution without displacement.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20105904.jpg\" width=\"473\" height=\"450\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Colles fracture:</strong> A Colles' fracture is a distal radius fracture with dorsal displacement, commonly seen in older adults after a fall on an outstretched hand, but it does not involve the first metacarpal.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20105916.jpg\" width=\"561\" height=\"301\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">A Bennett's fracture involves the base of the first metacarpal with displacement due to muscle pull, often resulting from a fall on an outstretched hand.</span></li></ul>",
      "correct_choice_id": 221993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80911,
      "choices": [
        {
          "id": 322328,
          "text": "<p><span style=\"font-size:12.0pt;\">Tolerance</span></p>"
        },
        {
          "id": 322329,
          "text": "<p><span style=\"font-size:12.0pt;\">Persistent desire to quit drug</span></p>"
        },
        {
          "id": 322330,
          "text": "<p><span style=\"font-size:12.0pt;\">Consumption of large amounts of drug over a prolonged period</span></p>"
        },
        {
          "id": 322331,
          "text": "<p><span style=\"font-size:12.0pt;\">Use of illegal substances</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of drug dependence?</span><span style=\"font-size:16px;\"> (NEET PG 2016)</span></p>",
      "unique_key": "Q5361949",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947314,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. Use of illegal substances</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Use of illegal substances is not a diagnostic feature of drug dependence. Drug dependence is defined by specific psychological and physiological features related to substance use patterns and their effects, regardless of whether the substance is legal or illegal. Dependence can develop to legal substances (such as alcohol, prescription medications) just as it can to illegal substances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Tolerance (Incorrect)</strong>: Tolerance is a core feature of drug dependence, defined as \"increasing amounts of a substance are required to get the desired effect.\" As the body adapts to the presence of the substance, more is needed to achieve the same psychoactive effects, which is a hallmark sign of dependence.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Persistent desire to quit drug (Incorrect)</strong>: A persistent desire or unsuccessful efforts to cut down or control substance use is a recognized feature of dependence. This represents the loss of control aspect of addiction, where individuals recognize the problems caused by their substance use but struggle to stop despite their intentions.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Consumption of large amounts of drug over a prolonged period (Incorrect)</strong>: Taking the substance in larger amounts or over a longer period than was intended is a characteristic feature of dependence. This reflects the impaired control over substance use that defines dependence.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dependence is characterised by a strong drive to use the substance, as manifested by&nbsp;</span></p><ol><li><span style=\"font-size:12.0pt;\">Tolerance- Increasing amounts of a substance are required to get the desired effect&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Withdrawal symptoms: Typical symptoms that develop when the substance intake is reduced or stopped.</span></li><li><span style=\"font-size:12.0pt;\">Craving- Strong desire or urge to use the substance</span></li><li><span style=\"font-size:12.0pt;\">Inability to control substance taking behaviour in terms of its onset, termination or levels of use.</span></li><li><span style=\"font-size:12.0pt;\">Continued use of a substance despite clear harmful consequences.</span></li><li><span style=\"font-size:12.0pt;\">Progressive neglect of other interests because of substance use.</span></li></ol>",
      "correct_choice_id": 322331,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6527,
      "choices": [
        {
          "id": 26077,
          "text": "<p><span style=\"font-size:12.0pt;\">Epinephrine</span></p>"
        },
        {
          "id": 26078,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucagon</span></p>"
        },
        {
          "id": 26079,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine</span></p>"
        },
        {
          "id": 26080,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactic acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elderly man with diabetic nephropathy presented to the emergency department with palpitations and chest discomfort. The ECG revealed large T-waves. Laboratory tests revealed elevated potassium levels. Which of the following drugs can cause intracellular movement of potassium? (NEET PG 2022)</span></p>",
      "unique_key": "Q8079383",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947328,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Epinephrine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beta 2 agonists (like Salbutamol and Epinephrine) and Insulin help in the intracellular movement of K<sup>+</sup>. These drugs therefore can decrease serum potassium levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The drugs that can be used in the management of acute hyperkalemia are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Salbutamol</span></li><li><span style=\"font-size:12.0pt;\">Glucose + Insulin (DOC)</span></li><li><span style=\"font-size:12.0pt;\">Calcium gluconate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In case of chronic hyperkalemia, K<sup>+</sup> binding resins like Patiromer and Polystyrene sulfonate can be used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Glucagon</strong>:<strong> </strong>Glucagon primarily works to increase blood glucose levels by promoting glycogenolysis and gluconeogenesis. It does not play a significant role in shifting potassium intracellularly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Atropine</strong>:<strong> </strong>Atropine is an anticholinergic drug that blocks muscarinic receptors. It is not involved in potassium homeostasis or its intracellular movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Lactic</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>acid</strong>:<strong> </strong>Lactic acid does not facilitate the intracellular movement of potassium. In fact, metabolic acidosis (which can be associated with elevated lactic acid levels) tends to cause potassium to move out of cells into the extracellular space, exacerbating hyperkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beta-2 agonists, such as Epinephrine, are effective in promoting the intracellular movement of potassium, thereby reducing serum potassium levels in cases of hyperkalemia.</span></p>",
      "correct_choice_id": 26077,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6509,
      "choices": [
        {
          "id": 26005,
          "text": "<p><span style=\"font-size:12.0pt;\">Lisinopril</span></p>"
        },
        {
          "id": 26006,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Nifedipine</span></p>"
        },
        {
          "id": 26007,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Atenolol</span></p>"
        },
        {
          "id": 26008,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Clonidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was started on antihypertensive drugs. Few days later, the patient presented with the following picture. Which of the following drugs is the most likely cause? (NEET PG 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/04/1_SqCWkWZ.jpg\" alt=\"\" width=\"250\" height=\"308\"></span></p>",
      "unique_key": "Q5850259",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947187,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Lisinopril</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given picture is suggestive of angioedema. The antihypertensive drug that can lead to the development of angioedema is ACE-Inhibitors – Lisinopril in the given option. Angioedema caused by ACE inhibitors is a class effect, and patients who experience this side effect should not be given any other ACE inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Nifedipine</strong>: Nifedipine is a calcium channel blocker used to treat hypertension and angina. It can cause side effects such as headache, flushing, and peripheral edema, but it is not typically associated with angioedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Atenolol</strong>: Atenolol is a beta-blocker used to treat hypertension and other cardiovascular conditions. Its common side effects include bradycardia, fatigue, and cold extremities, but it does not cause angioedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Clonidine</strong>: Clonidine is an alpha-2 adrenergic agonist used to treat hypertension. It can cause side effects such as dry mouth, sedation, and rebound hypertension upon abrupt withdrawal, but it is not associated with angioedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Side effects of ACE-Inhibitors are:-</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Angioedema</span></li><li><span style=\"font-size:12.0pt;\">Cough</span></li><li><span style=\"font-size:12.0pt;\">Taste disturbances (Dysguesia)</span></li><li><span style=\"font-size:12.0pt;\">Orthostatic hypotension</span></li><li><span style=\"font-size:12.0pt;\">Hyperkalemia</span></li><li><span style=\"font-size:12.0pt;\">They are contraindicated in Pregnancy and in patients with B/L Renal artery stenosis.</span></li></ul>",
      "correct_choice_id": 26005,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57290,
      "choices": [
        {
          "id": 228537,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methimazole</span></span></p>"
        },
        {
          "id": 228538,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></p>"
        },
        {
          "id": 228539,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propylthiouracil</span></span></p>"
        },
        {
          "id": 228540,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radioactive iodine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman at 8 weeks of gestation is diagnosed with hyperthyroidism. Which of the following is the most appropriate treatment option? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q2055917",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947190,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Propylthiouracil</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During the first trimester of pregnancy, Propylthiouracil (PTU) is the preferred treatment for hyperthyroidism. This preference is due to the fact that PTU has a lower risk of causing birth defects compared to Methimazole, which is associated with a rare but serious condition called aplasia cutis (a congenital skin defect). PTU is considered safer in early pregnancy, especially during organogenesis (the first trimester), as it crosses the placenta less readily than Methimazole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Methimazole:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methimazole is typically avoided during the first trimester because it is associated with teratogenic effects, particularly the risk of aplasia cutis and other congenital abnormalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Carbimazole:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole is a prodrug that is converted to Methimazole in the body. Like Methimazole, it is also avoided during the first trimester due to the risk of congenital defects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Radioactive iodine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radioactive iodine is contraindicated in pregnancy at any stage, as it can destroy fetal thyroid tissue, leading to permanent hypothyroidism in the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the first trimester of pregnancy, Propylthiouracil (PTU) is the preferred treatment for hyperthyroidism due to its lower risk of causing birth defects compared to other antithyroid medications.</span></span></span></p>",
      "correct_choice_id": 228539,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6510,
      "choices": [
        {
          "id": 26009,
          "text": "<p><span style=\"font-size:12.0pt;\">Phospholipase A2</span></p>"
        },
        {
          "id": 26010,
          "text": "<p><span style=\"font-size:12.0pt;\">Thromboxane Synthesis</span></p>"
        },
        {
          "id": 26011,
          "text": "<p><span style=\"font-size:12.0pt;\">Phospholipase C</span></p>"
        },
        {
          "id": 26012,
          "text": "<p><span style=\"font-size:12.0pt;\">Phospholipase D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient on aspirin presented with occult blood in the stool. This is due to inhibition of_____ by aspirin? (NEET PG 2021)</span></p>",
      "unique_key": "Q4229975",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947317,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Thromboxane Synthesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thromboxane A2 is a substance that promotes platelet aggregation and also causes vasoconstriction. Aspirin inhibits the enzyme cyclooxygenase (COX), which is crucial for the synthesis of thromboxane A2. By inhibiting thromboxane synthesis, aspirin reduces platelet aggregation, which can increase the risk of gastrointestinal bleeding, manifesting as occult blood in the stool.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Phospholipase A2</strong>: This enzyme is involved in the initial step of arachidonic acid release from cell membranes, but it is not directly inhibited by aspirin. The effect of aspirin is more downstream in the arachidonic acid pathway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Phospholipase C</strong>: Phospholipase C is involved in intracellular signaling but is not inhibited by aspirin. It does not play a direct role in the mechanism by which aspirin may cause occult blood in the stool.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phospholipase D</strong>: Similar to Phospholipase C, Phospholipase D is not inhibited by aspirin and is not involved in the mechanism leading to gastrointestinal bleeding from aspirin use.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, in this patient, the occult blood in the stool is most likely due to the inhibition of thromboxane synthesis by aspirin, making option B the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Aspirin inhibits thromboxane synthesis by irreversibly inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to reduced platelet aggregation and an increased risk of gastrointestinal bleeding.</span></p>",
      "correct_choice_id": 26010,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20911,
      "choices": [
        {
          "id": 83608,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 83609,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 83610,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 83611,
          "text": "<p><span style=\"font-size:12.0pt;\">Spironolactone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with a previous history of myocardial infarction and ventricular arrhythmia is on treatment for the same since a few months. He developed fatigue, dyspnea, and weight gain. He had also developed pulmonary fibrosis. Which of the following drugs is responsible for the above-mentioned side effects? (NEET PG 2023)</span></p>",
      "unique_key": "Q2503005",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947169,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Amiodarone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The drug that is responsible for the above-mentioned side effects is amiodarone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Amiodarone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">→ Longest acting [t1/2 → &gt; 3 weeks] anti-arrhythmic drug</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">→ MOA →</span></p><ol><li><span style=\"font-size:12.0pt;\">Na+ channel Blocker</span></li><li><span style=\"font-size:12.0pt;\">β-Blocker (Non-competitive)</span></li><li><span style=\"font-size:12.0pt;\">K+ channel Blocker [Main action]</span></li><li><span style=\"font-size:12.0pt;\">Calcium channel blocker</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">→ Indicated in all arrhythmias except Torsades de pointes</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">→ Adverse effect of amiodarone:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture6.jpg\" alt=\"\" width=\"1000\" height=\"292\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Atenolol</strong>: Atenolol is a Selective Beta 1 Blocker. C/I in Bradycardia, AV Block and Acute CHF. It is used in HTN, Classical angina, MI, Chronic CHF, Arrythmia</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aspirin</strong>: Aspirin is only irreversible COX Inhibitor, anti-platelet drug. C/I in child with viral infection (Due to Reye’s syndrome). Can cause Hyperuricemia at therapeutic doses - avoid in gout</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Spironolactone</strong>: Spironolactone is classified under potassium-sparing diuretic. Promotes sodium diuresis but maintains the body's potassium levels. C/I in patients with hyperkalemia. Can cause gynecomastia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Amiodarone&nbsp;</strong>is associated with a range of serious side effects, including pulmonary fibrosis, thyroid dysfunction, liver toxicity, and photosensitivity.</span></p>",
      "correct_choice_id": 83608,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20910,
      "choices": [
        {
          "id": 83604,
          "text": "<p><span style=\"font-size:12.0pt;\">Sacubitril</span></p>"
        },
        {
          "id": 83605,
          "text": "<p><span style=\"font-size:12.0pt;\">Omapatrilat</span></p>"
        },
        {
          "id": 83606,
          "text": "<p><span style=\"font-size:12.0pt;\">Losartan</span></p>"
        },
        {
          "id": 83607,
          "text": "<p><span style=\"font-size:12.0pt;\">Nesiritide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Name the drug that acts on both the marked points: (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture3.jpg\" alt=\"\" width=\"700\" height=\"488\"></span></p>",
      "unique_key": "Q1848764",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947159,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Omapatrilat</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Omapatrilat is a inhibits both neprilysin and Angiotensin-converting enzyme (ACE). As a result, there is a decrease in Angiotensin II and increase in natriuretic peptide levels, promoting natriuresis, diuresis, vasodilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Sacubitril:&nbsp;</strong>Sacubitril inhibits neprilysin reducing breakdown of vasoactive peptides such as natriuretic peptides and bradykinin, therefore increasing their levels leading to vasodilation, diuresis, and counteracting the effects of RAAS. Sacubitril is combined with an ARB, valsartan is indicated for the treatment of heart failure with reduced ejection fraction (HFrEF).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Losartan</strong>:<strong> </strong>Losartan is classified under angiotensin receptor blocker, used in the treatment of hypertension. A/E are Hyperkalemia, Dysgeusia, Postural hypotension. C/I in pregnancy, B/L Renal Artery Stenosis. Losartan decreases serum uric acid levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Nesiritide:</strong></span><span style=\"font-size:12pt;\"> Nesiritide is a synthetic brain natriuretic peptide (BNP), acts as a natriuretic and vasodilator. Primarily used in acute decompensated heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Omapatrilat inhibits both neprilysin and angiotensin-converting enzyme, thereby decreasing angiotensin II and increasing natriuretic peptides, promoting natriuresis, diuresis, and vasodilation.</span></p>",
      "correct_choice_id": 83605,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80899,
      "choices": [
        {
          "id": 322280,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteoporosis is a relative contraindication for ECT.</span></p>"
        },
        {
          "id": 322281,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzodiazepines should be discontinued prior to ECT.</span></p>"
        },
        {
          "id": 322282,
          "text": "<p><span style=\"font-size:12.0pt;\">The most common complication is Amnesia.</span></p>"
        },
        {
          "id": 322283,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased intracranial pressure is an absolute contraindication for ECT.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are true about Electroconvulsive therapy (ECT), except:</span><span style=\"font-size:16px;\"> (NEET PG 2015)</span></p>",
      "unique_key": "Q1448287",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947173,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. Increased intracranial pressure is a contraindication for ECT.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to current understanding, there are no absolute contraindications for ECT.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Osteoporosis is a relative contraindication for ECT (Correct)</strong>: Osteoporosis is indeed a relative contraindication for ECT because the muscle contractions during the seizure could potentially cause fractures in patients with severe osteoporosis. However, with modern modified ECT using muscle relaxants, this risk is significantly reduced.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Benzodiazepines should be discontinued prior to ECT (Correct)</strong>: Benzodiazepines should be discontinued before ECT because they have anticonvulsant properties that can raise the seizure threshold and potentially interfere with the therapeutic efficacy of ECT by reducing seizure duration.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. The most common complication is Amnesia (Correct)</strong>: Memory disturbances, particularly retrograde amnesia, are the most common side effects of ECT. Retrograde amnesia is more common than anterograde amnesia, and recovery typically occurs within 1-6 months.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While ECT requires careful consideration of patient-specific factors, there are no absolute contraindications for its use. Earlier, raised intracranial pressure was considered an absolute contraindication for ECT, but no longer. The main side effect is memory disturbance, particularly retrograde amnesia, which is usually temporary. Modern modified ECT using anaesthesia and muscle relaxants has significantly improved the safety profile of this effective treatment for severe depression, catatonia, and certain other psychiatric conditions.</span></p>",
      "correct_choice_id": 322283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20913,
      "choices": [
        {
          "id": 83616,
          "text": "<p><span style=\"font-size:12.0pt;\">Postural hypotension</span></p>"
        },
        {
          "id": 83617,
          "text": "<p><span style=\"font-size:12.0pt;\">Receptor upregulation</span></p>"
        },
        {
          "id": 83618,
          "text": "<p><span style=\"font-size:12.0pt;\">Rebound hypertension</span></p>"
        },
        {
          "id": 83619,
          "text": "<p><span style=\"font-size:12.0pt;\">Receptor hypersensitivity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A chronic smoker was on nicotine replacement therapy and clonidine tablets for smoking de-addiction. He stopped taking clonidine tablets and now presents with a headache. What is the reason behind this condition? (NEET PG 2023)</span></p>",
      "unique_key": "Q5822746",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947189,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Rebound hypertension</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clonidine is an alpha-2 agonist and a centrally acting antihypertensive agent. Used in HTN. Stimulates presynaptic α-receptor in the vasomotor centre in the brainstem, suppressing the release of norepinephrine and other sympathomimetics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clonidine sudden stoppage causes Rebound HTN and sympathetic overactivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment of clonidine withdrawal is Phentolamine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Postural Hypotension</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Description:</strong> A condition where blood pressure drops significantly upon standing up.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> Clonidine can cause postural hypotension, but sudden discontinuation leads to rebound hypertension, not postural hypotension.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Receptor Upregulation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Description:</strong> An increase in the number of receptors on the cell surface.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> This concept is more related to long-term exposure to antagonists, not the sudden withdrawal of an agonist like clonidine.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Receptor Hypersensitivity</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Description:</strong> Increased sensitivity of receptors to a stimulus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> While receptor hypersensitivity can occur, it is not the primary mechanism behind the headache and rebound hypertension seen with sudden clonidine withdrawal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Rebound hypertension</strong> is a critical condition that can occur when clonidine, an alpha-2 agonist, is suddenly discontinued. This results in a rapid increase in sympathetic activity, leading to symptoms such as headache due to a sudden spike in blood pressure.</span></p>",
      "correct_choice_id": 83618,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44830,
      "choices": [
        {
          "id": 178967,
          "text": "<p><span style=\"font-size:12pt;\">Drug A is competitive inhibitor and drug B is un-competitive inhibitor</span></p>"
        },
        {
          "id": 178968,
          "text": "<p><span style=\"font-size:12pt;\">Drug A is competitive inhibitor and drug B is non-competitive inhibitor</span></p>"
        },
        {
          "id": 178969,
          "text": "<p><span style=\"font-size:12pt;\">Drug A is non-competitive inhibitor and drug B is competitive inhibitor</span></p>"
        },
        {
          "id": 178970,
          "text": "<p><span style=\"font-size:12pt;\">Drug A is un-competitive inhibitor and drug B is competitive inhibitor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following statements regarding the drugs shown in graph A and graph B is correct. (</span>INICET May 2024)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/22/screenshot-2024-05-22-155759.png\" alt=\"\" width=\"400\" height=\"160\"></p>",
      "unique_key": "Q9825503",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947176,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans&nbsp;B) Drug A is competitive inhibitor and drug B is non-competitive inhibitor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">To determine the correct answer, let's analyze the Lineweaver-Burk plots and the types of enzyme inhibition they represent:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For non-competitive inhibitors, the lines intersect at the x-axis. This type of inhibitor decreases VmaxVmax​ without affecting KmKm​.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Competitive Inhibition</strong>: On a Lineweaver-Burk plot, competitive inhibitors intersect with the no-inhibitor line at the y-axis. This is because competitive inhibitors increase the apparent KmKm​ (Michaelis constant) without affecting VmaxVmax​ (maximum velocity).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Uncompetitive Inhibition</strong>: Uncompetitive inhibitors result in parallel lines on the Lineweaver-Burk plot. They decrease both VmaxVmax​ and KmKm​ proportionally.</span>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Given the descriptions of the graphs:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Graph A</strong>: The lines meet at the y-axis, indicating competitive inhibition.</span></li><li><span style=\"font-size:12pt;\"><strong>Graph B</strong>: The lines start from the same point on the x-axis, indicating non-competitive inhibition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>B. Drug A is competitive inhibitor and drug B is non-competitive inhibitor</strong></span></p>",
      "correct_choice_id": 178968,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20912,
      "choices": [
        {
          "id": 83612,
          "text": "<p><span style=\"font-size:12.0pt;\">N-acetyl cysteine to replenish glutathione stores</span></p>"
        },
        {
          "id": 83613,
          "text": "<p><span style=\"font-size:12.0pt;\">Pralidoxime</span></p>"
        },
        {
          "id": 83614,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucagon to control bradycardia and hypoglycemia</span></p>"
        },
        {
          "id": 83615,
          "text": "<p><span style=\"font-size:12.0pt;\">Give sodium bicarbonate to alkalize urine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young female is brought to the emergency department. Attendants inform that she has consumed 100 tablets of aspirin. What should be the next step in management? (NEET PG 2023)</span></p>",
      "unique_key": "Q9843767",
      "question_audio": null,
      "question_video": null,
      "map_id": 23947179,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Give sodium bicarbonate to alkalize urine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Aspirin poisoning (Salicylism)</strong></span></p><p>&nbsp;</p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">Respiratory Center Stimulation</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">↓</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">Hyperventilation</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">↓</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">↓CO<sub>2</sub></span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">↓</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">Respiratory Alkalosis → Reversible</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">↓</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">Metabolic Acidosis → Irreversible</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment - DOC is sodium bicarbonate (NaHC03)</span></p><ul><li><span style=\"font-size:12.0pt;\">&nbsp;Reverses metabolic acidosis</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;Helps in aspirin excretion</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. N-acetyl cysteine to replenish glutathione stores</strong>: N-acetyl cysteine is an antidote for paracetamol poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong></span><span style=\"font-size:11pt;\"><strong>.&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Pralidoxime</strong>: Pralidoxime is useful in organophosphate poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong></span><span style=\"font-size:11pt;\"><strong>.&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Glucagon to control bradycardia and hypoglycemia</strong>: Glucagon is antidote in beta-blocker toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Sodium Bicarbonate</strong> is the treatment of choice in aspirin poisoning, as it helps to alkalize the urine and enhance the excretion of salicylates, while also correcting metabolic acidosis.</span></p>",
      "correct_choice_id": 83615,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}